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Abstract 
The uterine environment in which a fetus grows and develops is now recognised as 
a risk factor for the development of adult diseases such as cardiovascular disease 
(CVD). A fetus relies on the nutrients and conditions delivered via the placenta, and 
as such the placenta plays a vital role in the establishment and maintenance of 
appropriate uterine conditions. Unfavourable uterine conditions such as an 
inadequate resource flow from the placenta can lead to diminished growth of the 
fetus and may ultimately result in both short and long-term increases in risk of CVD 
for the baby. This has been demonstrated in large observational cohort studies and 
has been corroborated in animal experiments. Despite these findings, there remains 
significant variability in the association between the fetal environment and adult 
disease risk in observational data across human populations. Moreover, the size of 
the association between the placenta, as master of the uterine environment, and 
CVD is yet to be quantified. In order to bridge this knowledge gap, the present study 
conducted a systematic literature search and meta-analysis of published data 
examining the effects of the placenta on cardiovascular outcomes across the life 
course.  
A systematic search was carried out and results were collated and assessed, with 
records which met the selection criteria then entered in to a meta-analytical process 
which included a funnel plot, calculation of Egger’s Regression Intercept and 
estimation of effect size. The results of the search indicated that the association 
between placental weight and CVD risk had been investigated in a total of 109,721 
participants across eight countries. The meta-analytical process initially indicated 
that higher blood pressure was related to a lighter placenta. On further inspection of 
the funnel plot, a distinct outlier was detected. This outlier was removed and the 
remaining records were analysed again. This second analysis indicated that higher 
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blood pressure was related to a heavier placenta. This process demonstrated that a 
single large study can substantially alter the results of a meta-analysis. Further, the 
variety of confounding variables which a study can adjust for demonstrates that 
placental weight cannot be viewed in isolation. None of the placenta studies relating 
placental weight to cardiovascular outcomes (such as mortality and morbidity) were 
comparable in this meta-analysis, indicating that there needs to be some guide to 
uniformity in the data collection and analysis. Such a guide would lead to better 
reporting and comparability between studies enabling new knowledge to build on 
previous research in this field. Ultimately, improved comparability of these studies, 
along with the transition of this field towards more complex measures of the placenta 
such as thickness, circumference and volume as well as the use of real-time imaging 
of the placenta, as the fetus develops in-utero, will contribute another dimension to 
our understanding of the relationship between placental function and adult disease 
risk. 
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1. Introduction. 
Cardiovascular Disease (CVD) is a major chronic, non-communicable disease and in 
2015 the World Health Organisation (WHO) reported that CVD accounted for 31% of 
all global deaths and 45% of deaths caused by non-communicable diseases (WHO, 
2017). The burden of CVD is seen not only in mortality rates, but also in ongoing 
symptom control and treatment. In Australia, it was estimated that in 2013-2014, the 
Pharmaceutical Benefits Scheme (PBS) provided payments totalling AUD$1.7 Billion 
(17% of total payments) for cardiovascular related medications (Nichols et al., 2016). 
Major dietary, lifestyle, and metabolic risk factors for CVD have been identified (e.g. 
hypertension, high blood cholesterol, smoking, sedentarism, and obesity), however, 
the majority of these manifest in adult life and for some people these signs and 
symptoms come too late to allow for any meaningful lifestyle change. 
The Developmental Origins of Health and Disease (DOHaD) paradigm suggests that 
the early environment, specifically the uterine environment, may have an effect on 
cardiovascular morbidity and mortality. DOHaD is a new health and research 
paradigm that was born in the 1980s from a growing body of evidence indicating that 
poor fetal growth can have life-long consequences for chronic health conditions 
(Barker, 1994). Longitudinal studies in humans and experimental studies using 
animal models (see section 1.5) have since supported and refined the concept that 
insults in early life influence subsequent mortality in adulthood from diseases 
including cardiovascular disease (CVD) and stroke (Baird et al., 2016). 
Within the DOHaD paradigm, there has been a strong research emphasis on birth 
weight as the independent variable representing the quality of the uterine 
environment the developing fetus has experienced. This has proven fruitful with a 
consistent association between reduced birth weight (or fetal growth) and increased 
risk of hypertension and CVD. This consistent inverse relationship has been evident 
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in times where infant and maternal mortality were low, as found in The Aberdeen 
Children of the 1950s study cohort (Lawlor et al., 2005). This cohort of 10,803 
singleton births lived through a time of profound improvements in infant and maternal 
health, therefore, factors other than the quality of healthcare, namely, genetics and 
variations in placental function were implicated (Lawlor et al., 2005). 
Focusing on birth weight as the main measure of the early environment, however, 
has misdirected the research focus to some extent. Birth weight is an outcome of the 
uterine environment rather than a cause of CVD. Birth weight is at the end of a long 
nutrition and oxygen supply line from the mother via the placenta to the fetus. 
Because of this relationship, the uterine environment, placenta and fetal growth are 
inextricably linked. Therefore, examining an alternative measure of the early 
environment – placental weight – and its association with subsequent cardiovascular 
health may provide additional insights. This is of particular interest when it is 
recognised that  a range of proposed cues (e.g. oxygen and nutrient levels, stress, 
and hormone levels) present during pregnancy are either influenced or regulated by 
the placenta and it is this which ultimately determines the physiological fitness of the 
heart (Thornburg et al., 2010). It has been calculated, from a sample of 24,152 
singleton liveborn children from the Collaborative Perinatal Project, that placental 
weight alone accounted for 36.6% of birth weight variation (Salafia et al., 2008). 
In order to quantify the strength of the association between placental weight and 
cardiovascular disease risk, the present study will synthesise published research and 
conduct a meta-analysis to provide a deeper and more complete understanding of 
the association between placental weight and CVD.  
The aim of this project is to bring together and evaluate the placental weight and 
cardiovascular health literature and attempt to quantify this relationship through the 
calculation of an effect size. This knowledge will contribute to our understanding of 
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the significance of the early environment for CVD and potential interventions aimed 
at improving placental and fetal growth and development.   
1.1 Hypertension and Cardiovascular Disease. 
Chronic non-communicable diseases exhibit an increasing health burden on the 
world’s population. Cardiovascular disease (CVD) is a major chronic, non-
communicable disease and the World Health Organisation (WHO) reported that 
globally in 2015, there were 17.7 million deaths attributed to CVD (equating to 31% 
of all global deaths or 45% of deaths by non-communicable diseases) and Australia 
is no exception (WHO, 2017). Nichols et al. (2016), reported that CVD was 
responsible for 45,392 deaths in Australia in 2015 (nearly 30% of all deaths). The 
burden of disease is seen not only in mortality, but also in ongoing treatment as our 
health services improve. It was estimated that in 2013-2014, the Pharmaceutical 
Benefits Scheme (PBS) in Australia provided AUD$1.7 Billion worth of payments 
(17% of total payments) for cardiovascular related medications (Nichols et al., 2016).  
The WHO defines CVD as diseases of the heart, vascular diseases of the brain and 
diseases of blood vessels, and categorises all CVDs into two groups, CVDs due to 
atherosclerosis and CVDs due to other causes. CVDs such as ischaemic heart 
disease (IHD) or coronary heart disease (CHD, of which ‘heart attacks’ are listed as 
a prime example), cerebrovascular disease (stroke), disease of the aorta and 
arteries, including hypertension and peripheral vascular disease, are all in the first 
category. The second category includes congenital heart disease, rheumatic heart 
disease, cardiomyopathies and cardiac arrhythmias (WHO, 2011). 
The WHO lists hypertension as a leading cause of CVDs as it is a key metabolic risk 
factor for atherosclerosis. Hypertension as a risk factor is recognised through the 
measurement of systolic and diastolic blood pressures (reported in mm Hg as 
SBP/DBP e.g. 120/80 is a SBP of 120 mm Hg and a DBP of 80 mm Hg). The risk of 
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CVD may double for each incremental increase of 20/10 mm Hg beginning at 115/75 
mm Hg, leading to CHD and cerebrovascular disease. Furthermore, uncontrolled 
hypertension contributes to heart failure, renal impairment and peripheral vascular 
disease, as well as visual impairment as it may damage retinal blood vessels (WHO, 
2011). 
According to both the WHO and the National Heart Foundation of Australia (NHFA), 
hypertension is intrinsically linked to CVD. The WHO released a “Global Brief on 
Hypertension” in 2013 naming it the ‘silent killer’ and a ‘global public health crisis’ 
(WHO, 2013; Nichols et al., 2016). Hypertension contributes to the burden of CVD, 
stroke and kidney failure and in many cases leads to premature mortality (WHO, 
2013). Of the 17.7 million deaths due to CVD worldwide in 2017, it was estimated 
that hypertension was responsible for at least 45% of coronary heart disease deaths 
and 51% of deaths due to stroke (WHO, 2017).  
The NHFA and the WHO recognise that the majority of deaths due to CVD are in low 
to middle socio-economic regions of the world. In the more developed regions the 
outlook for CVD is positive due to improved health and medical services (WHO, 
2013; Nichols et al., 2016). The knowledge base regarding CVD risk factors has 
developed largely from the Framingham Heart Study, which began in 1948, and was 
conducted by the National Heart, Lung, and Blood Institute (NHLBI) of the United 
States (Franklin & Wong, 2013). The Framingham Heart Study has led to the 
identification of the major CVD risk factors - high blood pressure, high blood 
cholesterol, smoking, obesity, diabetes, and physical inactivity. In addition, a great 
deal of valuable information has been collected on the effects of related factors such 
as blood triglyceride and High Density Lipoprotein (HDL) cholesterol levels, age, 
gender, and psychosocial issues (Franklin & Wong, 2013). These risk factors 
manifest in adult life and for some these signs and symptoms may come too late to 
allow for any meaningful life change.  
15 
 
The known modifiable risk factors for CVD are largely based on lifestyle and 
nutrition. Danaei et al. (2009) estimated the mortality effects of twelve modifiable 
dietary, lifestyle, and metabolic risk factors in the United States of America (USA) 
and identified that smoking together with high blood pressure were responsible for 
the most deaths in the USA. Sedentary behaviour is another risk factor that is 
currently receiving attention, after Wilmot et al. (2012) performed a systematic review 
and meta-analysis which identified that more sedentary time was associated with a 
significantly increased risk of cardiovascular disease (RR=2.47; 95% CI: 1.44, 4.24) 
and cardiovascular mortality (HR=1.90; 95% CI: 1.36, 2.66). 
The Developmental Origins of Health and Disease (DOHaD) paradigm suggests that 
the early environment, specifically the uterine environment, may have an effect on 
cardiovascular morbidity and mortality (Baird et al., 2016). Thus, understanding the 
risk factors for CVD in the early years, particularly during gestation and at birth has 
the potential to provide long-term benefits in reducing the burden of CVD.  
1.2 Developmental Origins of Health and Disease (DOHaD). 
DOHaD is a new health and research paradigm that was born in the 1980s from a 
growing body of evidence indicating that poor fetal growth can have life-long 
consequences for chronic health conditions (Barker, 1994). Longitudinal studies in 
humans and experimental studies using animal models (see section 1.5) have since 
supported and refined the concept that insults in early life influence subsequent 
mortality in adulthood from diseases including cardiovascular disease (CVD) and 
stroke (Baird et al., 2016).  
The DOHaD paradigm highlights the importance of the early environment for health. 
The premise is that certain diseases (including cardiovascular disease, obesity, type 
2 diabetes and metabolic disturbances, osteoporosis, chronic obstructive pulmonary 
disease, some forms of cancer, and mental illnesses) have their origins in the very 
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early stages of life (conception, pregnancy, infancy and early childhood) (Barker, 
2003). Initial studies that generated the original Barker Hypothesis, and the idea of 
uterine programming, which later became DOHaD, were conducted by David Barker 
in Hertfordshire, England. Thanks to the meticulous records of midwives in the 
county under the leadership of Ethel Margaret Burnside, Barker was able to follow up 
these babies 50 years later and found an association between their birth records and 
adult disease patterns (Barker, Bull, Osmond, and Simmonds, 1990). 
There had been concern at the start of the 20th Century that the health of the British 
population was in decline and it was decided in 1903 to vigorously preserve the life 
of every infant born. In 1911, Ethel Burnside was appointed “chief health visitor and 
lady inspector of midwives” in Hertfordshire. She proceeded to organise and train 
midwives of the county to educate new mothers on ways to keep their newborns 
healthy. Part of her duties was to keep records of infant birth weight plus weight at 1 
year (Barker, 2003). 
In the 1980s at Southampton University, David Barker and his research group began 
the search for maternity and infant health records from the early 20th Century. Many 
had been destroyed but some had been preserved and although the quality of the 
observations was inconsistent, varying from county to county, the largest and most 
complete set of recordings were those of Ethel Burnside and her team in 
Hertfordshire (Barker, 2003). 
From this point Barker & Osmond (1986) could see that there was an association 
between infant mortality, childhood nutrition and ischaemic heart disease. They 
found a strong correlation between the rate of infant mortality at the time of birth and 
the development of ischaemic heart disease in the surviving babies later on in life. 
The records showed that a birth cohort with a high infant mortality rate, most likely 
due to poor nutrition, were more likely to develop ischaemic heart disease. They 
17 
 
investigated the causes of infant mortality only to find that it was largely due to 
adverse environmental conditions (poor living standards) (Barker & Osmond, 1986). 
Barker and Osmond’s early work was shaped by Chapin’s 1909 ideas that the 
nutrient intake of infants has a bearing on their metabolism later in life. It was 
surmised that since fat is the major source of energy in human milk and has a 
correlation to ischaemic heart disease (IHD), it could be that fat metabolism is the 
associating factor between early life nutrition and adult disease (Barker & Osmond, 
1986). Although they could not measure the early uterine environment in this 
instance, birth weight was used as a proxy for the supply of nutrients to the fetus. 
As nutrition was central to Barker and Osmond’s concerns, it is important to consider 
both the nutrition of the mother and that of the fetus. Intrauterine growth of the fetus 
is both a function of the mother’s health and nutritional status and the fetal supply 
line including the efficiency of the placenta that ultimately nourishes the fetus. Barker 
et al. (1990, 1993) found that it is placental efficiency (how many grams of baby are 
produced per gram of placenta), which leads to a healthy birth weight. In turn, it is 
placental insufficiency that leads to intrauterine growth restriction (IUGR) which is 
now recognised as one of the markers of the early environment that subsequently 
contributes to an increased risk of adult disease. 
Barker (2003) stated that being small at birth or during infancy is a key indicator that 
sets people on developmental trajectories for the rest of their lives, with altered 
physiology that may ultimately increase their disease risk. He listed the following 
observed characteristics which set these people apart. 
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They have higher blood pressures and are more likely to develop type 2 
diabetes. They have different patterns of blood lipids, reduced bone density, 
altered stress responses, thicker left ventricular walls, less elastic arteries, 
and different hormonal profiles, and they are ageing more rapidly. Out of 
these observations has arisen the fetal origins hypothesis, which proposes 
that cardiovascular disease originates through the responses of a fetus or 
infant to undernutrition that permanently change the structure and function of 
the body. 
(Barker, 2003, p. 1430) 
1.3 Birth Weight, Fetal Growth and Cardiovascular Disease. 
Nutrition from birth through to adulthood has been identified as a contributing factor 
to high blood pressure and cardiovascular disease, therefore consistent with the 
DOHaD paradigm, it is likely that the nutritional status of an individual before birth 
will also be a significant factor. For many years, the nutritional status during 
gestation was summarised as the birth weight of the individual, which is routinely 
measured. Intuitively and empirically, a low birth weight is understood to be a poor 
outcome of gestation and depending on the severity it can reduce the individual’s 
survival probability.   
The WHO defines low birth weight (LBW) as less than 2500 grams and recognises 
that LBW is a significant public health matter by setting a 30% reduction target of 
LBW by 2025 (WHO, 2014). This target is focused on reducing preterm births in 
developing countries by improving antenatal care, nutrition and education. This is an 
admirable goal, however, not all low birth weight babies are preterm and not all 
preterm babies are of low birth weight (Wilcox, 2001). Therefore, reducing preterm 
birth may result in even more low birth weight babies being born. We are then faced 
with a situation where term babies have experienced their entire gestation under 
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restricted conditions, which may sometimes be diagnosed as intrauterine growth 
restriction. Intrauterine growth restriction (IUGR) has been defined as a rate of fetal 
growth that is less than normal for the growth potential of the fetus for that 
gestational age (Blair et al., 2005; Longo et al., 2013). The crucial mediator between 
the maternal environment, fetal growth and intergenerational health is the placenta, 
which is not as well studied.  
Many investigations into the association between the uterine environment and 
subsequent health outcomes have focused exclusively on birth weight. In a study of 
12,150 births from The Aberdeen Children of the 1950s study (born 1950-1956), 
Lawlor et al. (2005) investigated the association between birth weight of 10,803 
singleton births and vascular outcomes. The incidence of coronary heart disease and 
stroke were measured by way of hospital admissions or fatalities from these 
diseases, and an inverse relationship between birth weight and both these diseases 
was found. Furthermore, the authors stated that this was significant in times where 
infant and maternal mortality were low, indicating that this association held even 
when environmental circumstances were favourable to both the mother and child 
(Lawlor et al., 2005). The authors further state that the relationship was very strong 
and it is also independent of a number of factors, including adjustment for size in 
later childhood, social class and maternal and pregnancy characteristics. In addition, 
as the The Aberdeen Children of the 1950s study cohort lived through a time of 
profound improvements in infant and maternal health, Lawlor et al. (2005) noted that 
factors other than the quality of healthcare were at work, namely, genetics and 
variations in placental function. In their findings, Lawlor et al. (2005) surmised that 
the discovery of an inverse relationship between birth weight and incidence of 
cardiovascular disease at a time when there was low infant mortality strengthened 
the argument that birth weight could be an important predictor of cardiovascular 
disease.  
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This inverse association between birth weight and CVD mortality is also found when 
birth weight and subsequent blood pressure are investigated in observational 
studies, further supporting the link between birth weight, hypertension and CVD. A 
meta-analysis of 20 articles (reporting 27 original studies) showed that the inverse 
relationship was present with babies born of low birth weight (< 2500g) showing an 
increased risk of hypertension (OR=1.21; 95% CI: 1.13, 1.30) compared to a birth 
weight greater than 2500g. Similarly, mean systolic blood pressure (SBP) was 
shown to increase by 2.28 mm Hg (95% CI: 1.24, 3.33) in the low birth weight group. 
Conversely, babies of high birth weight (> 4000g) had a 2.08 mm Hg decrease in 
mean SBP compared to babies with birth weights less than 4000g (95% CI: -2.98, -
1.17) (Mu et al., 2012). 
Whether birth weight increased the risk of death generally or was specific to CVD 
was also explained. A meta-analysis that investigated 36,834 deaths using birth 
weight as the key predictor, has provided some insight into all-cause mortality, CVD 
mortality and cancer mortality, by calculating hazard ratios (HRs) and 95% 
confidence intervals (95% CI). From the 22 studies analysed, it was calculated that 
CVD mortality had a stronger inverse association with birth weight (HR=0.88; 95% 
CI: 0.85-0.91) than all-cause mortality (HR=0.94, 95% CI: 0.92-0.97) (Risnes et al., 
2011). Other mortality categories which were not consistently predicted by birth 
weight include cancer, cirrhosis of the liver, diabetes, diseases of the nervous 
system, lung diseases and mental disorders (Risnes et al., 2011).  
Evidence also suggests that the association between birth weight and vascular 
health varies between males and females. Gamborg et al. (2007), on behalf of the 
NordNet Study Group, performed a meta-regression analysis of 20 Nordic studies 
that synthesised the data from 197,954 births and found an inverse relationship 
between birth weight and systolic blood pressure (SBP) and a linear association with 
males and females having a birth weight greater than 4 kg. They estimated the effect 
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of birth weight on SBP at age 50 years for men to be -1.53 mm Hg/kg (95% CI: -
2.27, -0.77) and for women -2.80 mm Hg/kg (95% CI: -3.85, -1.76). The effect on 
women was nearly twice that of men. Due to these sex differences, this present 
study has attempted, where possible, to explore the evidence of an association 
between placental ratio and CVD for women and men separately.   
This strong research emphasis on birth weight has consistently shown an 
association between blood pressure and CVD, however, this has misdirected the 
focus to some extent. Birth weight is an outcome of the uterine environment rather 
than a cause of CVD. To further our understanding of the uterine environment, the 
relationship between the placenta and birth weight needs to be considered at the 
gross level as can be seen in a sample of 24,152 singleton liveborn children of the 
Collaborative Perinatal Project, where it was found that placental weight alone 
accounted for 36.6% of birth weight variation; the six other placental measures 
accounted for 28.1%. Combined, all placental measures accounted for 39.1% of birth 
weight variation (Salafia et al., 2008). The current study will establish the pooled 
effect size of placental weight and contribute to the future understanding of the 
predictive power of the early environment, specifically the placental weight and the 
subsequent development of CVD and hypertension.  
1.4 Placental Weight, Placental Efficiency and Cardiovascular 
Disease.  
As the growth of the fetus is determined to a large extent by the uterine environment, 
it can be seen that fetal growth, LBW and IUGR and the placenta, are inextricably 
linked. Fetal growth is dependent on the uterine conditions as nutrients are 
transported from the mother to the fetus via the placenta (Godfrey & Barker, 2000). 
Indeed, the importance of birth weight as a proxy for the end product of a long 
oxygen and nutrition supply line, has been questioned. For example, studies such as 
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those using data from the Dutch Hunger Winter Famine, suggest that early life 
exposures (predominantly maternal undernutrition) may not affect size at birth, yet 
still influence chronic disease risk (Barker, 1993; Ravelli et al., 1998; Lunney, 1998; 
Roseboom, 2011). As such, it may be that we need to look beyond birth weight and 
focus on attempting to identify additional factors that influence fetal growth (Whincup 
& Owen, 2006; Salavati et al., 2019).  
The most common pathophysiological mechanism for fetal growth restriction (FGR) 
is placental insufficiency. FGR fetuses are seen to occur in all fetal weight categories 
(small, appropriate and large for gestational age), however, there are limited studies 
focusing on placental morphometry and FGR. A recent review conducted by Salavati 
et al. (2019) indicated that morphometric data such as placental dimensions/shape 
and weight should be further explored as they contribute to placental insufficiency 
and can help to identify FGR. Moreover, placental conditions are the most frequent 
aetiology of IUGR (Mandruzzato et al., 2008). Key placental characteristics such as 
chorioangioma, infarction, circumvallate placenta, confined placental mosaicism and 
obliterative vasculopathy of the placental bed are all possible causes of IUGR. 
Therefore, examination of placental characteristics is a worthwhile activity to 
understand FGR and IUGR and provides an additional predictive factor for the risk of 
both reduced fetal growth and premature cardiovascular disease. If reliable 
predictors can be found, the potential to reduce the consequences of poor in-utero 
growth exist (Mandruzzato et al., 2008). 
A gross estimate of placental efficiency is calculated from its weight and the 
relationship between placental weight and birth weight has been demonstrated on 
several occasions in various cohorts around the world (Barker et al., 1990; Whincup 
et al., 1995; Godfrey & Barker, 2000). In a review of the placental origins of chronic 
diseases, Burton et al. (2016) defines one measure of placental efficiency to be the 
amount of fetal body mass accumulated per gram of placenta, as the key indicator of 
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the offspring’s resilience and susceptibility to chronic disease in later life. Burton et 
al. (2016) note that based on this measure of placental efficiency, the human 
placenta is relatively inefficient, suggesting that other evolutionary selective 
pressures have been more significant, namely, the placenta’s ability to mitigate 
maternal and environmental stressors through its endocrine and epigenetic 
adaptability. 
In recent times, larger longitudinal studies have added to the evidence base 
supporting the predictions of DOHaD and highlighted the importance of the 
placenta’s role in the uterine environment. Analysis of the Trondheim Cohort from 
Norway, a study of 31,307 Norwegians born between 1934 and 1959, found that the 
placental weight to birth weight ratio (placental ratio) was positively associated with 
cardiovascular disease mortality (Risnes et al., 2011). They concluded that either a 
disproportionately large placenta or a relatively growth restricted fetus increases the 
amount of work a fetus’ cardiovascular system needs to do and that this has 
consequences for development, specifically of the fetal cardiomyocytes. This, in turn, 
may limit capillary formation in the myocardium and lead to a poorly developed and 
susceptible cardiovascular system (Risnes et al., 2011). 
The consistent nature of these findings is further supported by the presence of 
similar associations in populations from developing countries. This is exemplified by 
the Mysore Parthenon study in Southern India with which Winder et al. (2011) 
investigated the factors that influence placental morphology. The authors concluded 
that the mother’s nutritional status and body size (mother’s height was measured in 
this study) were associated with greater placental efficiency. The neonates in this 
cohort are too young to follow up for cardiovascular mortality at present; however, an 
analysis of the 9.5 year blood pressure data concluded that the children’s blood 
pressure at 9.5 years can be predicted by the size and shape of the placental 
surface (Winder et al., 2011). This demonstrates the value of understanding factors 
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that influence the development of an efficient placenta and confirms that they apply 
in different environments and cross-culturally. Examination of the published evidence 
and estimating effect sizes in the current study should not only develop our 
understanding of associations between fetal growth, placental weight and 
cardiovascular disease, but may also contribute to the knowledge of which 
populations are more susceptible and require increased monitoring. 
In addition, other anthropomorphic markers of the uterine environment have also 
been used. Measures such as ponderal index, head to chest circumference ratio and 
placental ratio may be more sensitive indicators of restricted growth rather than birth 
weight and their association with CVD needs to be investigated. Using data from the 
Collaborative Perinatal Project in the United States, Hemachandra et al. (2006) 
examined 29,710 births between 1959 and 1965. At birth, anthropomorphic 
measurements such as birth weight, placental weight, and head and chest 
circumference, were obtained, and from this data they calculated the placental ratio, 
ponderal index and head to chest circumference ratios. The placental ratio is a 
common proxy for placental efficiency and is defined as the amount of fetus (in 
grams) produced per gram of placenta. The subjects were followed up and in their 
seventh year, their blood pressures were taken. Of all the measurements available, it 
was the placental ratio percentage, that is the weight of the placenta expressed as a 
percentage of the birth weight (calculated by dividing the placental weight by birth 
weight then multiplying by 100), that was associated with an increased risk for high 
systolic blood pressure and pulse pressure at seven years of age (Hemachandra et 
al., 2006).  
Although hypertension is rare among children, Misra and colleagues (2010) noted 
that blood pressure does track from childhood into adulthood. Several longitudinal 
studies have found that if a child has blood pressure at the higher end of the 
distribution, they are more likely to have hypertension as adults. They further 
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commented that there is a considerable amount of effort in place, focusing on 
nutrition and physical activity, which targets children at risk of developing 
hypertension in adult life. If we follow the DOHaD paradigm, there is considerable 
evidence supporting the idea that factors prior to the birth of the child are also at 
work. A subset of the Collaborative Perinatal Project (15,902 births) was analysed 
and it was found that birth weights smaller or larger than the predicted placental 
weight have a predictive effect on future blood pressure and body mass index (BMI). 
This effect was found to be independent of other measurements (Misra et al., 2010). 
The placenta gives unique insight into intrauterine conditions and placental growth 
may be linked to an increased life-time risk of hypertension and cardiovascular 
disease. Through calculating effect sizes, this present study aims to quantify the 
influence of the early environment more accurately in order to provide the evidence 
base for or against early interventions. 
1.5 Birth weight, placental weight and cardiovascular disease: 
Summary. 
In summary, the association between the uterine environment and its subsequent 
health consequences in humans has produced mixed findings, particularly with 
regard to the role of the placenta. This relationship was further investigated in 
relation to blood pressure and Barker (1997) discovered that at any given birth 
weight, blood pressure rose as placental weight increased. He suggested that 
people with the highest blood pressures as adults were in-utero, sacrificing their own 
growth to support placental growth, resulting in an increased placental ratio: a larger 
placenta with a smaller baby (Barker, 1997). This highlights how valuable placental 
growth is and that the placenta plays a key role in the uterine environment. 
Development of the fetus and birth weight are outcomes of this uterine environment 
and understanding the effect of the placenta on them and cardiovascular morbidity 
and mortality is crucial.  
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Although some studies find evidence for an important role of the placenta beyond 
that of birth weight (e.g. Hemachandra et al., 2006; Misra et al., 2010), others find 
birth weight is the key predictive factor (e.g. Blake et al., 2001; Huang et al., 2007; 
Lawlor et al., 2005). For example, Blake et al. (2001) studied 2,507 births between 
1989 and 1992 and recorded blood pressure at age 1, 3 and 6 years. In contrast to 
Barker (1997), they concluded that there was an inverse relationship between 
placental weight and blood pressure at 1, 3 and 6 years. However, there was no 
consistent relationship between placental weight and later blood pressure within birth 
weight categories and based on this finding, they surmised that it was not clinically 
significant.  
What we do know is that it is generally accepted that birth weight has been a long 
standing predictor of infant mortality and FGR (Wilcox, 2001; Salavati et al., 2019). It 
is reasonable to link fetal nutrition with fetal growth and ultimately birth weight. The 
ease of measurement and attainment of birth weight records has fostered a huge 
body of data examining birth weight and numerous infant and adult health outcomes 
(Wilcox, 2001). Birth weight itself, however, does not wholly explain the 
developmental consequences of placental insufficiency, IUGR or FGR, which does 
indicate that birth weight should be related as an outcome of placental insufficiency 
rather than a cause of future disease (Wilcox, 2001). It has been noted recently that 
in a normally nourished population, the small for gestational age (SGA) group may 
include those exhibiting placental insufficiency, those in which no signs of placental 
insufficiency have been detected or represent unknown or undetected causes of 
placental insufficiency or those with congenital malformations or infections (Figueras 
& Gratacos, 2017). In order to separate out the cause, that is, maternal and fetal 
nutrition from the effect, which is measured as placental and fetal growth, animal 
models have been utilised.  
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1.6 Animal Models 
Animal models have been usefully applied in biology and medicine to investigate 
potential mechanisms underlying associations seen at the group level. These models 
are particularly useful for investigating the mechanisms behind DOHaD effects, 
consequently, a number of small and large animal models as well as novel models 
have been developed for this purpose (Bertram & Hanson, 2001). Animal models 
have long been used to demonstrate that maternal nutrition may program adult 
disease (Bertram & Hanson, 2001). Indeed the first experiments relating to the 
current DOHaD concept may have been run over 50 years ago by Winick & Noble 
(1966). The association between birth weight and CVD noted by Barker and 
colleagues (1990, 1993, 1994, 1997) worldwide have been supported through the 
use of animal models. Therefore, the following section will discuss the use of animal 
models to investigate mechanisms underlying the DOHaD phenomenon. These 
models have been used to develop the knowledge base of DOHaD and continue to 
refine our understanding of the effect the placenta has in animal populations.  
These models indicate that insults during critical periods of embryonic and fetal 
development can have permanent long-term effects on organ structure and function, 
and regulatory systems of the body, which ultimately impact adult health (Jones et 
al., 2012). Collectively, it has been shown that effects on the placenta or fetal heart 
depend on the nature of the challenge and the duration, severity and timing in 
relation to the development of the heart and placenta (Camm et al., 2018). 
Presently, there are a number of established animal models used with some being 
less invasive, for example, using dietary protein restriction or global nutrient 
restriction to induce IUGR (McMullen & Mostyn, 2009; Jones et al., 2012). Others 
are more invasive, using techniques such as uterine ligation or the in-utero removal 
of part of the placenta (Bertram & Hanson, 2001; McMullen & Mostyn, 2009). These 
animal models demonstrate that IUGR offspring develop post-natal hypertension, a 
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known contributing factor to cardiovascular disease. Small animal models, such as 
mice, rats and guinea pigs, also have a number of benefits including shorter 
gestation times and short lifespans which affords us the opportunity to investigate 
the DOHaD concept in ways that cannot be done in humans (Jansson & Lambert, 
1999; Bertram & Hanson, 2001; Symonds, et al., 2007; Wyrwoll et al., 2007; 
McMullen & Mostyn, 2009; Camm et al., 2018). 
A range of animal models have been used to investigate environmental factors that 
link the phenotypic characteristics of the placenta to those of the heart. These 
models comprise three broad groups: 1) Those that reduce oxygen and nutrient 
delivery to the fetus (these include various forms of ligation of the key arteries and 
veins); 2) Those that reduce oxygen availability for transfer to the fetus (these 
include various forms of inhalation hypoxia); and 3) Those that alter nutrient 
availability for the fetus (these include maternal dietary restrictions) (Camm et al., 
2018). The methods employed in these three categories cannot be ethically 
replicated in randomised trials of human populations, therefore, for human 
populations, it is left to observational studies or studies based on natural 
experiments (e.g. the Dutch Famine and other factors which may impose a dietary 
restriction) or in cases of clinical placental pathology such as abnormal umbilical 
cord insertion (Camm et al., 2018). A fourth group does exist as the administration of 
glucocorticoids (usually synthetic) in experimental animal models and in humans to 
hasten development in pre-term birth. Due to the weight of evidence from animal 
experiments it is generally accepted that the efficiency of the placenta is associated 
with the efficiency of the cardiovascular system. 
Furthermore, animal models have the added dimension of experiments conducted 
on genetically modified organisms. In describing the relationship between placental 
formation and fetal heart development, findings from genetically modified mouse 
experiments suggest that fetal heart development requires several genes which also 
29 
 
regulate the development of the placenta (Camm et al., 2018). This adds further 
evidence to the causal nature of the association between placental function and 
heart development. 
A search of The Mouse Genome Informatics database, conducted in February 2018 
by Camm et al., identified 329 genes with both placental morphology and 
cardiovascular defects (2018). 24 of these genes were included in a review of 
placenta and fetal heart interactions and all of these genes highlight the impact of 
placental development on fetal heart formation and growth, with malformations of the 
heart and placenta cited as the most common cause for mid-gestational lethality in 
mice (Camm et al., 2018). Furthermore, the previous focus was largely centred on 
assessing the impact of a genetic manipulation rather than the interaction between 
placental formation and cardiac development (Camm et al., 2018).      
The physiological relevance of some animal models is questioned, often cited 
differences include the dietary requirements and the physiology and reproductive 
capacity, particularly of small animal models, as negatives (Bertram & Hanson, 
2001). It is true that rats or mice have different diets to humans, different disease 
profiles and their offspring are born with immature nervous systems in litters rather 
than singleton births with relatively mature nervous systems (a functioning 
Hypothalamic–Pituitary–Adrenal axis or HPA axis) common in humans. The guinea 
pig model has been used as the invasiveness of the placenta is significant and their 
offspring are relatively mature at birth, however, the other drawbacks of dietary and 
disease profile still remain (Bertram & Hanson, 2001; McMullen & Mostyn, 2009). 
Even in the face of these drawbacks, rat and mouse models using uterine artery and 
vein ligated placenta have been shown to result in hypertensive offspring in rats and 
mice (Bertram & Hanson, 2001). 
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Large animal models which are less like the rat and mouse model, are used by 
researchers as some are perceived to be closer to humans in physiology. Three 
large animal models considered are the sheep, the pig and non-human primates, all 
of which have offspring born with a functioning HPA axis. Non-human primates 
afford us the greatest insight, however, ethically, morally and financially the use of 
such a model is controversial and restricted. There are other factors that impact on 
the use of non-human primates such as the age at reproductive maturity, which 
could be between 4 and 7 years. This incurs a further increase in costs for care in 
captivity, as well as our responsibility for their physical and mental well-being 
requiring many resources and expertise. In most countries, these factors are 
prohibitively expensive (McMullen & Mostyn, 2009).  
Natural experiments in pig and sheep populations occurring on farms, have provided 
supporting anecdotal evidence for the relationship between the placenta and fetal 
development, and these results are anecdotally referred to as the ‘runt of the litter’ 
effect (Bertram & Hanson, 2001). In a commercial age where every animal born 
needs to provide a monetary return to the farmer, it is considered an important factor 
to study in order to avoid financial loss. Natural experiments in pigs occur due to the 
anatomy of the pig’s uterus, as it is ‘U’ shaped, the fetus attached to the ends of the 
arms of the ‘U’ have a natural restriction and it is easily a demonstration of how a 
naturally restricted placenta results in poor birth outcomes such as LBW. 
Experiments in sheep in which ligation of placentae are easily done due to the bi-
lobed nature of the sheep’s placenta reduced the overall size of the ligated placenta 
by half, and the resulting offspring exhibit IUGR characteristics (McMullen & Mostyn, 
2009).     
Where the sheep fails to match humans in dietary intake, the pig matches a human’s 
omnivorous diet and so, a porcine model for DOHaD is emerging. In the porcine 
model, due to the large litter size and variability in uterine environment, piglets of the 
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same litter may have up to a 3-fold difference in birth weight. It is this unique feature 
of the pig and the fact that they can be assessed within litters which provides a 
natural model of variable fetal growth conditions (McMullen & Mostyn, 2009). 
With regard to the investigation of DOHaD and cardiovascular disease, animal 
models routinely demonstrate that IUGR results in hypertensive offspring. Alexander 
(2003) conducted an experiment on rats whereby placental perfusion was reduced to 
induce IUGR and observed that the IUGR rats had a marked elevation in mean 
arterial pressure at four, eight and twelve weeks of age when compared to controls. 
Furthermore, at twelve weeks of age, the rats showed a differentiation based on sex, 
with IUGR male rats showing an increased mean arterial pressure vs male controls 
(158±1 versus 135±2 mm Hg, P<0.01), whereas female IUGR rats showed an 
increase that was not significant (139±4 versus 126±3 mm Hg; IUGR versus control, 
respectively, no p-value supplied) (Alexander, 2003). Ojeda et al. (2008) states that 
animal models have been used to demonstrate how an environment of under 
nutrition, by reducing uteroplacental perfusion during late gestation, leads to 
hypertension in the IUGR offspring. Findings such as these in animal models parallel 
human epidemiological studies where reduced placental efficiency is related to 
cardiovascular mortality and morbidity in the offspring.  
Animal models have also afforded proof of concept for DOHaD by allowing 
investigations into specific causal mechanisms. They provide an analogy enabling us 
to study the DOHaD concept and allow us to experiment in ways that would be 
unethical, immoral or unfeasible in a human population. Bilateral uterine blood vessel 
ligation in rat models has been used to induce uteroplacental insufficiency and this 
has been associated with reduced birth weights and increased systolic blood 
pressure and pulse pressure in adult rats (Schreuder et al., 2006). One of the most 
likely mechanisms appears to be a reduced number of nephrons in the kidneys of 
these growth restricted animals. This appears to hold for several animal models 
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including diet restriction (Woods et al., 2004). This association between lower birth 
weight, a reduced nephron number and increased blood pressure is also supported 
by human data (Hughson et al., 2003; Manalich et al., 2000). Animal models 
continue to be refined with new guidelines specific to their use in DOHaD research in 
order to continue accumulating knowledge into the effects of genome, environment 
and epigenetics (Dickinson, 2016). 
1.7 Epigenetics and DOHaD. 
The role epigenetics play in the DOHaD paradigm has also been investigated using 
animal models. This is of particular interest as the paradigm views the fetal insult as 
a ‘programming’ process implying the embodiment of the stressor as a precondition 
for disease in later life. A mouse model showed that there are at least two global 
epigenetic reprogramming events which can be related to the DOHaD concept, the 
first being the mass deletion of the parental genome followed by a selective 
epigenetic re-programming of the gametes during gametogenesis while the second 
occurs after fertilisation within the zygote which enables the pluripotency of the cells 
(Symonds et al., 2007). 
The mouse model provides support that in humans, following fertilisation, maternal 
and paternal genomes (excluding the imprinted genes) of the developing zygote 
undergo demethylation in order to ensure that the cells are pluripotent. This 
demethylation is undone in 70% of Cytosine-phosphate Guanine dinucleotides 
(CpGs) prior to implantation, but following implantation, DNA methylation continues 
to be vital in cell differentiation as it silences the expression of specific genes during 
the development of tissues and organs. This results in a window of opportunity, 
where if an insult were to occur during this time, then variations in gene expression 
can result (Godfrey et al., 2007; Einstein et al., 2010).  
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In addition to the effect on the offspring’s genome, epigenetic regulation is a 
significant factor in the development of the placenta and its function. Nelissen et al. 
(2010) reviewed the literature on epigenetics in relation to placental development 
and function in order to further examine this claim. It was noted that the proper 
epigenetic regulation of both imprinted and non-imprinted genes is crucial to 
placental development and this, in turn, is key to a developing fetus (Nelissen et al., 
2010). Showing further support for the DOHaD paradigm, Nelissen et al. (2010), 
concluded that various environmental factors can disturb the epigenetic regulation 
process leading to abnormal placental development with possible consequences to 
the offspring’s susceptibility in later life.  
Banister and colleagues (2011) examined 206 human placentae for genome wide 
DNA methylation patterns and found that it is possible to use patterns of DNA 
methylation to classify IUGR and small for gestational age (SGA) placentae from 
appropriate for gestational age (AGA) placentae. A significant difference (p = 0.0007) 
in the prevalence of IUGR or SGA placentae was found, which led them to conclude 
that DNA methylation profiles and IUGR  or SGA placentae are significantly 
associated (Banister et al., 2011). This adds a further factor to the complexity of the 
placental influence on the growth and development of the fetus. Through epigenetic 
modifications of the placenta and its function a complex array of alterations to the 
DNA have specific roles in the phenotype. Coall et al. (2015) proposed that 
methylation can occur in response to the external environment and this may be 
reversible, hence the changes are prime candidates for developmental adaptations 
as seen in DOHaD.  
It has been observed that the key regulators of growth and development of blood 
vessels within the placental villi are members of the Vascular Endothelial Growth 
Factor (VEGF) family (David, 2017). These include VEGF-A, or the processed forms 
of VEGF-C and VEGF-D which bind to VEGF receptor 2 (VEGFR-2) which result in 
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vasculogenesis and angiogenesis in the placenta, increasing placental efficiency. In 
IUGR mice models, this is inhibited and a soluble form of VEGF-2 is formed which 
binds VEGF-A, subsequently inhibiting its actions (David, 2017). 
The preceding reviews of human studies and animal models strongly advocate for 
the existence of a link between the placenta and the offspring’s subsequent 
cardiovascular health. Thus it can be seen that the DOHaD paradigm is well 
supported, however, the mechanism adopted to describe the uterine environment is 
not clearly defined. There is a large body of evidence in support of the use of birth 
weight while other data shows support for the placental ratio percentage as a marker 
of the uterine environment. A range of proposed haemodynamic, growth factor, 
stress and nutrient or oxygen cues before birth are either influenced or regulated by 
the placenta and it is this that determines the ultimate physiological fitness of the 
heart (Thornburg et al., 2010). The next step is to quantify the strength of the 
association between placental weight and cardiovascular disease risk. The current 
study is a synthesis of the published data and a meta-analysis to provide a deeper 
and more complete understanding of the association between placental weight and 
CVD. Therefore, generating an effect size from a meta-analysis of observational data 
in human populations may contribute further to our understanding of and the value of 
potential interventions aimed at improving placental growth, development, and 
structure and ultimately function.  
This project will: 
1) Examine the published evidence on the associations between in-utero growth 
of humans (focusing on placental weight measurements and the placental 
ratio percentage) on cardiovascular outcomes (hypertension and 
cardiovascular morbidity as defined by the WHO ICDs) in adult life by 
performing a systematic review. 
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2) Use meta-analytical techniques to synthesize the information found through 
the systematic review.  
3) Use the PRISMA statement to report the findings from the published data on 
human studies.    
2. Materials and Methods. 
 
2.1 Systematic Literature Search 
To examine the published data describing the effect of placental weight on 
cardiovascular outcomes, a broad and as complete as possible range of published 
work was assessed. To access this work, the search terms were carefully selected 
taking into account different spelling, word combinations, research and disease 
terms. Search terms included the following and/or combinations of, ‘birth weight’, 
‘birthweight’, ‘IUGR’, ‘fetal weight’, ‘foetal weight’, ‘placental weight’, ‘placental weight 
ratio’, ‘placental ratio’, ‘hypertension’, ‘high blood pressure’, ‘stroke’ and 
‘cardiovascular disease’. The search was restricted to studies on human, singleton 
births and articles written in English published up to and including the 30 December 
2017. These search terms have been chosen using key definitions set out by the 
WHO and are in line with the original findings underlying the Developmental Origins 
of Health and Disease paradigm.  
A systematic search of the following databases, PubMed, EMBASE and ISI Web of 
Science, was conducted and the results recorded in the PRISMA flow chart (Figure 
1; Chapter 3 below) and a spreadsheet (Appendix A). Searching the PubMed 
database was considered valuable as it covers publications in the biomedical and life 
sciences fields of research and is linked to the US National Library of Medicine. This 
enabled the search to cover the MEDLINE database (in total PubMed covers 27 
million references) and in addition, the database is indexed using a controlled 
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vocabulary termed MeSH - Medical Subject Headings. MeSH suggested search 
terms which are approximates to the original terms entered for example, ‘placenta 
weight’ was recommended by MeSH in lieu of ‘placental weight’. Searching the Web 
of Science database, expanded the literature search to include books and 
conference proceedings. In addition to journals, this maximised the probability of 
accessing grey literature, that is, data which may have been discussed as part of a 
conference or book chapter but was not published in a journal. To broaden the scope 
of the search further, the EMBASE database was searched as it covers journals that 
are not included in the MEDLINE database (searched through PubMed).  
The database searching was conducted as follows. First, the BMJ, PLoS One and 
PLoS Medicine journals were searched in full, as these are journals of quality where 
significant research groups in the field of DOHaD have published repeatedly. 
Second, the databases (PubMed, EMBASE and ISI Web of Science) were searched 
followed by a Google Scholar search. The Google Scholar search was employed as 
an additional layer to maximise reach and diversity as it employs meta-searches 
rather than direct database searches. A detailed list of the articles found was 
maintained in order to avoid duplicates. 
When the systematic literature search was carried out, the relationship between the 
placenta and the cardiovascular system was investigated, the most common 
placental measures being used were placental weight and placental weight to birth 
weight ratio (sometimes referred to as the placental ratio). It is becoming more 
apparent that other placental measures such as volume, surface area, length and 
breadth are increasingly being used. As more studies using these measurements are 
published a better understanding of the placenta’s role in CVD will emerge. As this is 
emerging literature, the search criteria for this thesis was focused on placental 
weight measurements. In the original defining work by Barker and colleagues (1986), 
placental weights were measured in imperial pounds, whereas subsequent 
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investigations used metric measurements (grams). The cardiovascular outcomes 
have been defined by the WHO using the International Classification of Diseases 
(ICD) codes to identify cardiovascular diseases such as ischaemic heart disease 
(IHD), coronary heart disease (CHD) and stroke. In addition, blood pressure was 
investigated alongside hypertension as blood pressure was sometimes measured in 
children and this was seen as separate to diagnosed hypertension in adults.    
2.2 Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA).  
The best practice guidelines for conducting and reporting meta-analyses and 
systematic reviews are provided in the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) statement, developed and published by The 
PRISMA Group. This statement was released via simultaneous publications in the 
British Medical Journal (BMJ), Annals of Internal Medicine, PLoS Medicine, Journal 
of Clinical Epidemiology, Open Medicine and the International Journal of Surgery. 
This statement recognised that while meta-analyses and systematic reviews are 
essential tools used to provide a reliable and accurate view of published data, there 
is evidence that the published works resulting from a systematic review and/or meta-
analysis are often less useful than expected because the key information is not 
reported well (The PRISMA Group, 2009). This was most likely due to the lack of a 
standard protocol for reporting systematic reviews and meta-analyses. The PRISMA 
statement introduced a means for standardised reporting in order to provide a guide 
on how to report the findings (The PRISMA Group, 2009). In the current project, the 
PRISMA statement guidelines were followed, and in doing so, the transparent and 
complete reporting of key information was ensured (The PRISMA Group, 2009), see 
Figure 1 for this study’s PRISMA 2009 Flowchart. 
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2.3 Statistical Analysis. 
Through a systematic review of the published works, a list of studies was created as 
displayed in appendix A. The studies were examined and data was extracted from 
them in these eleven fields: 1) Publication details (e.g. authors, date and title of 
publication), 2) Setting or cohort studied, 3) Recruitment location, 4) Method of 
measurement, 5) Diagnostic criteria to determine CVD, 6) Age at outcome, 7) 
Number of subjects, 8) Placental weight categories, 9) Other placenta data, 10) Key 
findings and 11) Comments. 
The studies were grouped according to the type of cardiovascular outcome measure 
(e.g. hypertension, coronary heart disease and cerebrovascular disease), and further 
stratification was made based on geographical regions and/or population. If data was 
available on sex this was also used to group data. Once the groupings were set up, 
meta-analytical techniques (as defined by the PRISMA statement) were performed.  
To analyse the data a specialised meta-analysis package, Comprehensive Meta-
Analysis (CMA) software from https://www.meta-analysis.com/ was used. CMA was 
chosen as it does not restrict the type of data entered for the calculation of effect size 
and variance to one format, for example, means and standard deviations. The CMA 
software accepts more than one hundred formats including the more frequently 
used, mean and standard deviation, odds ratio and confidence intervals, increasing 
the number of studies that can be incorporated into the analysis. 
The first technique was the examination of publication bias which was done through 
the use of funnel plots. Publication bias was first formalised by Dickersin & Min 
(1993) as a tendency for articles not to be published based on the direction and 
strength of the results of a study. It is now one of several biases related to meta-
analyses, collectively termed reporting biases (Sedgwick, 2013). A funnel plot is a 
plot of the estimated effect size of each trial against its sample size. By including a 
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funnel plot we visualised how the individual studies found, through the systematic 
review, were related to each other and explored the implications for data 
heterogeneity, publication bias and chance (Liu, 2011; Sedgwick, 2013). Of specific 
concern was the shape of the plot, as in the absence of bias, the plot resembles an 
inverted funnel indicating a balance between positive and negative results exists in 
the published literature. The shape comes from the commonly held statistical 
understanding that results from studies of smaller sample size will scatter widely 
across the bottom of the funnel plot because a smaller sample size lends itself to 
greater variability and this spread of effect sizes will narrow as the sample sizes 
increase (Egger et al., 1997).  
Symmetry can be assessed visually providing a quick method to determine if 
publication bias exists, however, to be certain, calculated statistics are employed. In 
this instance an Egger’s test was performed. The null hypothesis for Egger’s test is 
that symmetry exists in the funnel plot, with the alternative indicating that asymmetry 
is present and there is evidence of publication bias (Egger et al., 1997; Sedgwick, 
2013). When the Egger’s test was applied, if the resulting p-value was greater than 
0.05 it indicated that there was no evidence to reject the null hypothesis in favour of 
the alternative, indicating that symmetry was present and there is no evidence of 
publication bias. This indicated that at the 5% level of significance it could be 
concluded that symmetry exists in the funnel plot. Calculated p-values for the 
Egger’s test are recorded in Table 1.  
The meta-analysis consisted of three main parts. First, a pooled estimate and 
confidence interval for the condition’s effect size was calculated after combining all 
the studies. Second, a test for whether the condition’s effect size was statistically 
significant or not (i.e. does the effect differ from no effect more than would be 
expected by chance?). Third, a test for heterogeneity of the effect on outcome 
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between the included studies (i.e. does the effect vary across the studies more than 
would be expected by chance?). 
Discussion on the value of effect sizes by Sullivan and Feinn (2012) indicated that p-
values are not enough on their own. P-values are greatly influenced by sample size, 
with large sample sizes (which are common in this field of research) increasing the 
likelihood of a small effect size being statistically ‘significant’ without any clinical 
meaning. Therefore, an examination of each study in light of the calculated p-value 
and effect size was carried out, with the calculated effect sizes reported whenever 
possible. Cumming (2013) stated that effect sizes and confidence intervals provide 
the basis for estimation and the use of estimation is superior to null hypothesis 
testing. Meta-analytical techniques used in the current project are the key tool in 
synthesizing the records found through the systematic literature search. Effect sizes 
will quantify the placental risk factor enabling comparisons to other early (e.g. birth 
weight) and adult (e.g. hypertension) risk factors for CVD. 
Using the CMA software, the relevant data from the records were extracted and 
entered in the required fields and then the I2 statistic was calculated. The I2 statistic is 
a useful summary of the impact of heterogeneity in a data set as it describes the 
proportion of total variation that is due to heterogeneity (Higgins & Thompson, 2002). 
An I2 of less than 25% indicates that the studies should be combined using a fixed-
effects model as they are homogenous. Alternatively scores of greater than 75% for 
an I2 indicate that the studies are highly heterogeneous and a mixed-effects model 
should be used (Fernandez & Tran, 2009). After determining that a mixed-effects 
model should be used in this study (an I2 more than 25% was reported in section 
3.2), a meta-analysis was run and results displayed in Tables 2 and 3. The results 
included lower and upper limits for 95% CI, standard difference in means and 
variance of each study. These statistics provide a broader picture of the data and an 
estimate of the effect of each study on the overall calculated effect size.  
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2.4 Examination of Geographical Locations Studied. 
Records that satisfied the selection criteria were coded on a heat map of the world in 
order to generate a view of the most common locations where these studies were 
carried out. A further examination of these records in light of the geographic region 
was conducted and this is discussed in section 4.6. 
2.5 Grey Literature. 
Several records which were found through the search process did not satisfy the 
selection criteria and were deemed inappropriate for further analysis. These records 
were thoroughly searched and were found to cite two potentially unexplored links to 
the topic. 
The two possible links were: 
1. Eight groups identified by McNamara et al. (2012) who studied early life 
influences on cardio-metabolic health in aboriginal populations. 
2. A research group working out of the King Saud University who investigated 
changes in the placenta during and around Ramadan (Alwasel et al., 2011; 
Harrath et al., 2014). 
They were searched independently using Google Scholar and PUBMED. In addition, 
the corresponding authors were contacted via email as they may also have collected 
data which has not been published. 
2.6 Selection Criteria. 
On completion of the literature search the resulting studies were systematically 
reviewed. Search results which did not fulfil the above criteria (in addition to reporting 
on placental weights and CVD) were excluded from further analysis, but retained to 
provide possible insight and a search of their reference lists was conducted to 
extract relevant studies. 
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Records were screened using the following criteria: 
1) Records were written in English or a duplicate published translation. 
2) Records were an original report on the relationship between human placental 
weight and blood pressure, hypertension, cardiovascular disease, ischaemic 
heart disease, stroke or coronary heart disease. Studies were considered 
irrespective of the definition of cardiovascular disease (definitions used 
included those of the World Health Organisation and the National Heart 
Foundation). 
3) Records studied subjects of singleton births, born at full term. 
4) Records reported placental weight and the incidence of cardiovascular 
disease as described in point 2. 
5) Records indicated the geographical and/or ethnic group of the cohort studied 
If a record did not fulfil criteria 1, 2, 3 and 4, it was excluded from further analysis as 
the record was not usable. The records were retained in order to provide further 
insight and for a search of the reference list. Records that did not satisfy criteria 5 
were retained and included in the meta-analysis as this criterion did not impact on 
the record’s suitability for this meta-analysis. 
2.7 Analysis of Study Quality Using the Newcastle-Ottawa Scale. 
After the search was conducted and analysis was performed, it became apparent 
that further examination of the search results was required to provide additional 
evidence by which the quality of each study could be evaluated. The Newcastle-
Ottawa Scale (NOS) was used to assess the quality of the articles reported in this 
study and to examine outliers in the data. The NOS was developed in conjunction 
with the University of Newcastle (Australia), The University of Ottawa (Canada) and 
The Ottawa Hospital Research Institute. It has been used extensively at the 
University of Ottawa and the Ottawa Hospital Research Institute, most notably in a 
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project assessing the association of CHD with hormone replacement therapy in 
postmenopausal women (Wells et al., 2000). The Cochrane Collaboration and the 
Agency for Health Research and Quality (AHRQ) have identified the value of the 
NOS (AHRQ, 2010; Singh et al., 2015). It is noted that users who are unfamiliar with 
the field of research tend to require more training than those who are familiar with 
the field (Singh et al., 2015). Therefore, in order to maintain consistency, a 
systematic review and meta-analysis that employed the NOS was used as a guide to 
the ranking process. The article by Zhang et al. (2013) on, “The Associations of High 
Birth Weight with Blood Pressure and Hypertension in Later Life” ranked 30 articles 
that had a range of scores from four to nine stars. The author of this thesis read and 
ranked the articles according to the NOS and the scores were compared in order to 
develop consistent scoring. The present study used the NOS criteria specifically 
designed for cohort studies and this is reported in appendix B. 
Using the NOS, studies are ranked on three domains: Selection, Comparability and 
Outcome, with a maximum of nine stars to be awarded (these ratings are displayed 
in Figure 4). Domains for the NOS scale were defined on the basis of the search 
criteria of the present study. For example, in the first NOS Domain for ‘Selection’ 
under the heading, ‘Representativeness of the Cohort’ both the exposed and non-
exposed cohort was set to be of all singleton, full term babies in the community 
studied. Therefore, a star was awarded if there was ‘full representation’ (all singleton, 
full term babies in that population, sample, or hospital) or ‘somewhat representative’ 
and no stars were awarded if the study was restricted to one sex, for example. Under 
the NOS domain for ‘Comparability’, it was noted that as every article found reported 
a study which controlled for some factors, such as birth weight or age, it was 
deemed that although this was not consistently the same factor, there was an 
awareness that some factors in each study were acting as confounders and so one 
star was awarded to each study in this domain. According to the NOS guidelines, 
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another star was awarded if the study specifically controlled for age, sex and marital 
status. The final NOS domain was for ‘Outcome’, and it required an indication of the 
median duration of follow-up and it was defined that any study which included rates 
of mortality from CVD or incidence of hypertension or CVD was awarded a star 
indicating that the duration of follow-up was adequate. Studies which examined 
blood pressure (without the key diagnosis of hypertension) were not given a star. 
In relation to the NOS scoring system, the Agency for Healthcare Research and 
Quality (AHRQ) has indicated that there are three standards, Good, Fair and Poor. 
Good quality is defined as: Three or four stars in the ‘Selection’ domain, and one or 
two stars in the ‘Comparability’ domain and two or three stars in the ‘Outcome’ 
domain. Fair quality is defined as: Two stars in the ‘Selection’ domain and one or 
two stars in the ‘Comparability’ domain and two or three stars in the ‘Outcome’ 
domain. Poor quality is defined as: None or one star in the ‘Selection’ domain or no 
stars in the ‘Comparability’ domain or none or one star in the ‘Outcome’ domain. One 
article, Barker (1997) indicated with an asterix (*) in Figure 4 was ranked but it 
reported on data previously published and so was not counted as an original article 
for the purposes of the meta-analysis. This is further discussed in section 4.7. 
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3. Results. 
3.1 PRISMA Flow Diagram. 
The process and results of the search of the published literature is detailed in Figure 
1. This figure outlines the stages of ‘Identification’, ‘Screening’, ‘Eligibility’ and 
‘Inclusion’ with the appropriate number of records and details the prescribed steps at 
each stage as outlined by the PRISMA statement. The search identified 826 
potential articles through the database search and 18 articles from other sources 
such as the reference lists of relevant articles. After removing duplicates, 724 
records remained. An initial screening process found that the majority of these 
records were reporting on similar cohorts or were responses to the editor and/or 
authors of published articles and these 592 records were subsequently removed 
from the list. In addition, several records were reference texts, established 
procedural guidelines (e.g. guidelines for the pathological examination of the 
placenta) or recommendations for changes to the guidelines, which were also 
removed. Following this initial screening process, 132 records remained. A further 
103 records were excluded as they did not completely fulfil the selection criteria (as 
outlined in section 2.5). Although excluded, these 103 records were retained, their 
full texts obtained and searched in detail in order to extract any information which 
may have been overlooked. Three records were of use as they indicated: 
1. Eight groups identified by McNamara et al. (2012) who studied early life 
influences on cardio-metabolic health in aboriginal populations. 
2. A research group working out of the King Saud University who investigated 
changes in placenta during and around Ramadan (Alwasel et al., 2011; 
Harrath et al., 2014). 
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The appropriate correspondence authors were contacted via the email address 
supplied and a detailed search of their reference lists was conducted for potentially 
useful records. 
The full texts of the remaining 29 records were assessed and 3 were found to be 
unsuitable as they either used placental weights as part of a cluster analysis which 
analysed Percentage of Expected Birth Weight (PEBW), measured placental weights 
as an outcome of exposure to famine or the record was an analysis of a cohort which 
was previously included. The remaining 26 records were included in subsequent 
analyses. Of the 26, four records were found to reported sufficient data to enter into 
the meta-analysis in this study. The results of this meta-analysis are shown in Tables 
2 and 3.   
On entering the data into the CMA program it became apparent that the various 
combinations of data type (e.g. SBP, DBP, diagnosed hypertension, OR, RR, HR, 
SMR), placental weight groupings (grouping placentae into three, four and five 
groups) and use of differing methodologies (e.g. meta-regression or adjustments for 
different variables) would cause the data reported in the records to be incompatible. 
To gain a greater understanding of the quality and potential variability between 
studies, further analysis of the records was also employed. This included: 
1) To examine difference in geographical origins of the cohorts. 
2) To examine the quality of the studies using the Newcastle-Ottawa Quality 
Assessment Form for Cohort Studies. 
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Figure 1. PRISMA Flow Diagram displaying the number of records at each stage of 
the four stages of the prescribed PRISMA process. 
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3.2 Meta-Analysis of Records 
Of the 26 records, four supplied data in a compatible format which allowed a meta-
analysis to be performed and all four records focused on blood pressure as an 
outcome measure. One record collected blood pressure readings at three age points 
(1, 3 and 6 yrs) and this data was entered as three individual cohorts.The funnel plot 
for these records is displayed in Figure 2. 
One record (Whincup et al., 1995) was idenitified (shown as a red dot in Figure 2) as 
an outlier and the data was analysed again without this record, with the funnel plot 
for the repeat analysis shown in Figure 3. 
 
Figure 2. Funnel plot of standard error by standard difference in means, output from 
CMA. A record highlighted (red dot) was identified as an outlier. The diamond on the 
horizontal axis indicates the spread of the effect size as calculated by standard 
difference in means. 
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Figure 3. Funnel plot of standard error by standard difference in means, output from 
CMA. This plot has omitted the outlier, Whincup et al. (1995), from Figure 2. The 
diamond on the horizontal axis indicates the spread of the effect size as calculated 
by standard difference in means. 
 
Through visual examination of the plot an outlier was expected. An Egger’s test was 
performed to determine the level of heterogeneity in the studies, which leads to the 
selection of a mixed-effects or a fixed-effects model. The results of the Egger’s test 
are displayed in Table 1, with both 1-tailed and 2-tailed p-values affected by the 
removal of the outlying record. In the original analysis (Figure 2), both p-values 
indicated that asymmetry existed and after removing the record (Figure 3) the p-
values indicated that symmetry does exist (p>0.05) 
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Table 1. Egger’s Regression Intercept and p-value scores for the Egger’s test of the 
funnel plots with and without the outlier. 
 For all records  
(Figure 2). 
Omission of outlier 
(Figure 3). 
Intercept 63.239 -11.604 
Standard Error 17.267 7.722 
95% CI lower limit (2 
tailed) 
15.297 -36.180 
95% CI upper limit (2 
tailed) 
111.180 12.972 
 
t-value 3.662 1.503 
df 4.000 3.000 
p-value (1-tailed) 0.011 0.115 
p-value (2-tailed) 0.022 0.230 
 
The results from the meta-analysis including Whincup et al. (1995) can be seen in 
Table 2 while Table 3 displays the results from the meta-analysis omitting it. 
An I2 value of 99.4 was calculated and as it was greater than 75% it was determined 
that a mixed-effects model was appropriate, because, as noted by Fernandez & Tran 
(2009) mixed-effects models are usually reserved for I2 scores of greater than 75%. 
As displayed in Table 2, p-values indicate significant results from the Barker et al. 
(1990) and Whincup et al. (1995) records. One other record, Moore et al. (1996), had 
a p-value of 0.05. All three cohorts from the Blake et al. (2001) record are not 
significant. 
In this analysis (Table 2), the combined effect favoured a lighter placenta, indicating 
that higher blood pressure was related to a lighter placenta (Effect size = 0.250; p-
value<0.0005). An outlier (Effect size = 4.125; p-value<0.0005) which distinctly 
favoured a lighter placenta (Whincup et al., 1995) was noted. 
Once the outlier was removed, the analysis was re-run. Removing the outlier 
generated an I2 value of 55.5, and as it was greater than 25% it was determined that 
a mixed-effects model was appropriate, however, it is not greater than 75% and 
therefore an analysis was run using both fixed and random effects models. The 
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results are displayed in Table 3 and no difference was found between the fixed and 
random effects models in the calculated results.  
As displayed in Table 3, the effect sizes and p-values for indivudal studies remained 
the same as in Table 2. P-values indicate significant results from the Barker et al. 
(1990) and Whincup et al. (1995) records. The Moore et al. (1996) study retained the  
p-value of 0.05 and all three cohorts from the Blake et al. (2001) record are not 
significant. 
The combined effect however, is no longer significant and has changed to indicate 
that a higher blood pressure is related to a heavier placenta (Effect size = -0.044; p-
value = 0.24). 
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Table 2. Results of the meta-analysis performed. Blake et al. (2001) included subjects from three age categories and therefore each age 
category was treated as an individual cohort. Standard Difference in Means, Standard Error, Variance and Relative Weights were calculated 
and Lower and Upper limits are reported for 95% CI. The plot shows that overall the condition favours a lighter placenta, indicating that higher 
blood pressure is related to a lighter placenta. 
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Table 3. Results of the meta-analysis omitting the outlier (Whincup et al. (1995)), performed on 3 records. Blake et al. (2001) included subjects 
from three age categories and therefore each age category was treated as an individual cohort. Standard Difference in Means, Standard Error, 
were calculated and Lower and Upper limits are reported for 95% CI. The plot shows that overall the condition favours a heavier placenta, 
indicating that a higher blood pressure is related to a heavier placenta although it is not significant. 
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To further understand the quality of the research articles being assessed and further 
evaluate the removal of the outlier, an additional analysis of the quality of the studies 
was undertaken.  
The Newcastle-Ottawa Quality Assessment Form for Cohort Studies was employed 
and the results of the ranking are displayed in Figure 4. Of the 26 records ranked, 20 
(77%) were of good quality, three (12%) were ranked as borderline Good/Fair and 
another three were ranked as borderline Fair/Poor. 
The borderline Good/Fair ranking was used as these three records received only 1✯ 
in the Outcome domain (placing them in the Poor Category), however, they received 
sufficient scores in the other two domains to place them in the Good category. This 
meant that they were in the Good category for two out of three domains, but placed 
in the Poor category for one domain. Similarly, the Fair/Poor ranking was used 
because the three records in this category received 3✯ in the Selection Domain 
(placing them in the Good Category) and 1✯ in both the Comparability and Outcome 
Domains, which places them in the Poor Category. 
The Whincup et al. (1995) article which was originally identified as an outlier was one 
of two articles that received the highest possible score (nine out of nine ✯), 
therefore, it is not likely that it was an outlier or an error. The other records in the 
meta-analysis are not as highly ranked, with Barker et al. (1990) scoring 8✯, Moore 
et al. (1996) and Blake et al. (2001) both scoring 6✯. The other article which scored 
9✯ (Risnes et al., 2009) found that death by CVD had an increase in HR per SD 
(120g) of placental weight (HR 1.13, 95% CI 1.00, 1.28). Death by CHD had an 
increase in HR per SD (120g) of placental weight (HR 1.13, 95% CI 0.97, 1.33) and 
death by stroke Death had a decrease in HR per SD (120g) of placental weight (HR 
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0.083, 95% CI 0.87, 1.58). Therefore, the two highest ranked studies, both with 9✯, 
found diverging associations between placental weight and cardiovascular health.   
 Selection 
 
Co
mpa
rabi
lity 
Outcome  
Authors Design ✯ ✯ ✯ ✯ ✯ ✯ ✯ ✯ ✯ Total Quality 
Whincup et al. 
(1995) CH ✯ ✯ ✯ ✯ ✯ ✯ ✯ ✯ ✯ 9 
Good Quality 
Selection: 3 or 4 ✯ 
Comparability: 1 or 
2 ✯ 
Outcome: 2 or 3 ✯ 
Risnes et al. (2009) CH ✯ ✯ ✯ ✯ ✯ ✯ ✯ ✯ ✯ 9 
Barker et al. (1990) CH ✯ ✯ ✯ ✯  ✯ ✯ ✯ ✯ 8 
Barker et al. (2009) CH ✯ ✯ ✯ ✯  ✯ ✯ ✯ ✯ 8 
Eriksson et al. 
(2011)  CH ✯ ✯ ✯ ✯  ✯ ✯ ✯ ✯ 8 
Eriksson et al. 
(2000) CH ✯ ✯ ✯ ✯  ✯ ✯ ✯ ✯ 8 
Fan et al. (2009) CH ✯ ✯ ✯ ✯  ✯ ✯ ✯ ✯ 8 
Hesmati & Koupil 
(2014) CH ✯ ✯ ✯ ✯  ✯ ✯ ✯ ✯ 8 
Leon et al. (1998) CH ✯ ✯ ✯ ✯  ✯ ✯ ✯ ✯ 8 
Taylor et al. (1997) CH ✯ ✯ ✯ ✯  ✯ ✯ ✯  7 
Eriksson et al. 
(2010) CH ✯ ✯ ✯ ✯  ✯ ✯ ✯  7 
Barker (1997) * CH ✯ ✯ ✯ ✯  ✯ ✯ ✯  7 
Burke et al. (2004) CH ✯ ✯ ✯ ✯  ✯ ✯ ✯  7 
Barker et al. (1992) CH  ✯ ✯ ✯  ✯ ✯ ✯ ✯ 7 
Campbell et al. 
(1996) CH  ✯ ✯ ✯  ✯ ✯ ✯ ✯ 7 
Forsen et al. (1997) CH  ✯ ✯ ✯  ✯ ✯ ✯ ✯ 7 
Martyn et al. (1994) CH ✯ ✯ ✯ ✯  ✯ ✯ ✯  7 
Law et al. (1991) CH  ✯ ✯ ✯  ✯ ✯ ✯  6 
Martyn et al. (1996) CH  ✯ ✯ ✯  ✯ ✯ ✯  6 
Forsen et al. (1999) CH  ✯ ✯ ✯  ✯ ✯ ✯  6 
Whincup et al. 
(1999) CS ✯ ✯ ✯ ✯ ✯ ✯ ✯   7 
Good/Fair Quality.  
Selection: 4✯ 
Comparability: 1 or 
2✯ 
Outcome: 1✯  
Blake et al. (2001) CH ✯ ✯ ✯ ✯  ✯ ✯   6 
Moore et al. (1996) CH ✯ ✯ ✯ ✯  ✯ ✯   6 
Moore et al. (1999) LS  ✯ ✯ ✯  ✯ ✯   5 Fair/Poor Quality: 
Selection: 3✯ 
Comparability: 1✯ 
Outcome: 1✯  
  
Winder et al. (2011) CH  ✯ ✯ ✯  ✯ ✯   5 
Forrester et al. 
(1996) CH  ✯ ✯ ✯  ✯ ✯   5 
Figure 4. All 26 articles from the qualitative synthesis ranked from highest quality (9✯), to 
lowest quality (5✯). The Newcastle Ottawa Scale (NOS) the Quality Assessment Form for 
Cohort Studies.  
Note: A study can be given a maximum of nine stars across the three sections of Selection, 
Comparability and Outcome. The Agency for Healthcare Research and Quality (AHRQ) has 
indicated that there are three standards, Good, Fair and Poor. These are defined as Good 
quality: 3 or 4 ✯ in selection domain AND 1 or 2 ✯ in comparability domain AND 2 or 3 ✯ in 
outcome/exposure domain. Fair quality: 2 ✯ in selection domain AND 1 or 2 ✯ in 
comparability domain AND 2 or 3 ✯ in outcome/exposure domain. Poor quality: 0 or 1 ✯ in 
selection domain OR 0 ✯ in comparability domain OR 0 or 1 ✯ in outcome/exposure domain. 
One article, Barker (1997), indicated with an asterix (*) was ranked but it reported on data 
previously published and so was not counted as an original article. 
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3.3 Records Related to Blood Pressure: Qualitative Synthesis. 
To further understand the relationship between placental weight and CVD outcomes, 
the studies related to each outcome were analysed separately. Of the 26 records, 12 
focused on blood pressure, of which four (Barker et al., 1990; Whincup et al., 1995; 
Moore et al., 1996; Blake et al., 2001) were compatible for the meta-analysis. In this 
group of 12, two reported mean diastolic and systolic blood pressures (DBP and 
SBP), four reported mean SBP only (two reported group SD only and they were 
found to be reporting on the same cohort, the duplicate article is indicated with an * 
in Table 4) one used a calculation of mean difference and one reported incidence of 
diagnosed hypertension, one record reported only a p-value for linear trend while no 
records used DBP exclusively. In addition, there are four records which used either 
SBP or DBP as a factor in regression model analysis. These records are listed along 
with key information such as the placental weight categories used, direction of 
relationship and p-value for linear trend (where reported) in Table 4. Five records 
(42%) reported a positive relationship between placental weight and blood pressure 
(i.e. the condition favours a heavier placenta or a heavier placenta is associated with 
higher blood pressure). Four (33%) reported a negative relationship and two were 
mixed, with Winder et al. (2011) reporting a positive relationship for girls and a 
negative relationship for boys, conversely, Taylor et al. (1997) reported a negative 
relationship for girls and and a positive one for boys. One article was the duplicate 
study indicated with a asterix. 
Of the four records which reported mean SBP and DBP, one record reported the 
mean and a group standard deviation for the entire cohort, another record reported 
means only without standard deviations or confidence intervals or a similar statistic. 
One did not report any data but provided a descriptive statement on the relationship 
between placental weight and blood pressure. Two records split the cohort to 
compare boys and girls, one used means and standard deviations of SBP and DBP 
57 
 
and the other used regression modelling with SBP and DBP as factors. Table 4 
displays more detail for each study such as the reported regression coefficients, p-
values and direction of relationship.   
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Table 4. Results of literature search. Articles listed have reported both placental weights and an association with blood pressure. Placental 
weight categories, mean Systolic Blood Pressure (SBP), mean Diastolic Blood Pressure (DBP), direction of relationship (positive trend denotes 
an increase in blood pressure between lightest to heaviest placental weight categories), p-values for linear trends are listed when available in 
the published article. In some cases, SD, R2 and 95% CI were available and this has been noted in the table below. Of the twelve articles, five 
articles demonstrated a positive relationship, four demonstrated a negative relationship, two articles examined boys and girls separately, one 
found a negative trend for girls and a positive trend for boys, the second found a negative trend for girls DBP, boys SBP and DBP and a 
positive trend for girls SBP, the remaining article shared data from another study indicated with *. 
Authors Placental Weight 
categories 
Measure (SBP, DBP or 
both) 
Direction of 
relationship 
P-value for 
linear trend 
Other measures/ statements 
Blake et 
al. (2001) 
 
 
<540g 
541-640g 
>640g 
Mean SBP (95% CI) All regression 
coefficients for 
placental weight 
and SBP were 
negative.  
None reported The child’s current weight was the 
concurrent variable most strongly 
correlated with blood pressure. 
Placental weight was positively 
associated with current weight. 
No consistent pattern was seen in the 
relationship between placental weight 
and SBP within birth weight groups or 
overall. The highest SBP at age 6 years 
was in those children with the highest 
placental weight and lowest birth weight 
and the lowest SBP was in those with 
the lowest placental and highest birth 
weight 
1 yo 
98.3 
97.9 
97.2 
 
3 yo 
99.6 
99.1 
99.0 
 
6 yo 
104.3 
104.8 
104.8 
Moore et 
al. (1996) 
 
 
 
 
 
 
 
≤500g 
510-600g 
>600g 
Mean SBP and DBP  at age 
8 no SD reported 
Positive (SBP & 
DBP) 
 
None reported Placental weight alone was not related 
to systolic pressure. There was a 
positive but not statistically significant 
relationship between placental weight 
and diastolic pressure. 
 
 
 
SBP 
100.6 
101.5 
102.2 
DBP 
60.1 
60.7 
62.3 
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Barker et 
al. (1990) 
Placental weights 
in pounds 
(converted to 
grams) 
 
≤1.0 (≤454g) 
1.01-1.25 
(458.54-567.5) 
1.26-1.5 (572.04-
681) 
>1.5 (>681) 
RR SBP>160 mm Hg and RR 
Treatment for Hypertension 
Positive None reported Systolic and diastolic blood pressure 
were strongly related to placental 
weight. 
Mean differences were also calculated 
with 95% CI 
1st cohort Mean difference pw ≤1.5 lb 
and >1.5 lb, 11 mm Hg, 4 to 18) 
2nd cohort 7, 0 to 14 
Combined 9, 4 to 14 
The highest pressures were among 
people who had been small babies with 
large placentae and the lowest were 
among people who had been large 
babies with small placentae. 
SBP >160 
mm Hg  
 
1.0 (ref) 
1.3 
 
2.4 
 
3.0 
Treatment for 
Hypertension 
 
1.0 (ref) 
1.1 
 
1.2 
 
2.5 
Barker et 
al. (1992) 
Placental weights 
in pounds 
(converted to 
grams) 
 
≤1.0 (≤454g) 
1.01-1.25 
(458.54-567.5) 
1.26-1.5 (572.04-
681) 
>1.5 (>681) 
Mean SBP group SD 20.2 
age 46-54 
 
 
 
144 
148 
 
148 
 
156 
Positive None reported  
Barker 
(1997) * 
Same cohort and 
data as Barker 
(1992) 
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Law et al. 
(1991) 
 
 
 
 
≤550g 
650g 
750g 
>750g 
Mean difference SBP mm Hg 
and 95% CI age 4 years. 
 
 
0 (ref) 
-0.1 
0.6 
2.6 
Positive None reported  
Winder et 
al. (2011) 
 
 
 
 
≤350g 
400g 
450g 
>450g 
Mean SBP and DBP and SD 
Age 9.5 yr 
Negative (Boys – 
SBP and DBP, 
Girls DBP) 
 
Positive (Girls – 
SBP) 
0.15 (Boys 
SBP) 
 
0.24 (Boys 
DBP) 
 
0.8 (Girls SBP) 
 
0.02 (Boys 
DBP) 
Length, breadth and area of placenta. 
Boys Girls 
SBP 
102.5 
101.1 
103.6 
100.6 
DBP 
58.5 
58.7 
59.4 
57.5 
SBP 
99.4 
99.6 
100.1 
100.6 
DBP 
58.6 
58.6 
57.9 
56.6 
Burke et 
al. (2004) 
None used Regression Modelling age 8 
years 
Coefficient 0.003 
95% CI -0.001, 0.007 
 
Positive 0.169 
 
R2 0.001 
Campbell 
et al. 
(1996) 
None used Regression modelling 
Statement only 
Negative 0.2 Low placental weight was associated 
with a higher blood pressure in the 
offspring though this was not 
statistically significant(regression 
coefficient -9.2 mm Hg/kg; 95% CI -
22.6 to 4.1 
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Taylor et 
al. (1997) 
None used Regression modelling SBP 
and DBP boys and girls 8-11 
yr 
Negative (Girls) 
Positive (Boys) 
0.01 (Girls 
SBP) 
 
0.37 (Girls 
DBP) 
 
0.09 (Boys 
SBP) 
 
0.05 (Boys 
DBP) 
 
Difference in coefficients between boys 
and girls 
P value 0.002 (SBP), 0.05 (DBP) 
Girls Boys 
SBP 
-7.74 
DBP 
-1.79 
SBP 
4.27 
DBP 
3.21 
Whincup 
et al. 
(1995) 
 
 
 
Low ≤589g 
Middle 590 – 
689g 
High ≥690g 
 
Mean SBP and SE age 9-
11yr 
 
108.6 
105.6 
 
105.3 
Negative   
Whincup 
et al. 
(1999) 
None used Regression Modelling SBP 
and DBP SE and p value 
SBP 
Coefficient -0.007  
SE 0.003 
p value 0.01 
DBP 
Coefficient -0.005 
SE 0.002 
P value 0.02 
Negative 0.01 (SBP) 
 
0.02 (DBP) 
Effect of adjustment for birth weight 
examined 
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3.4 Records Related To Mortality or Morbidity. 
Of the 26 records inspected, ten investigated the association between placental 
weight and the risk of mortality by coronary heart disease (CHD), ischaemic heart 
disease (IHD), stroke, cardiovascular disease (CVD) and diagnosed hypertension. 
Table 5 lists these records and provides further details along with key information 
such as the placental weight categories used, measure of risk (e.g. odds ratio), 
direction of relationship and p-value for linear trend. Of the ten records, three used 
hazard ratios (HR), three used odds ratios (OR), two used standardised mortality 
ratios (SMR), one used a rate per 100,000 of population and one used cumulative 
incidence (percentage). Three records (30%) focused on diagnosed hypertension, 
one record observed the risk of death by stroke, CHD, and non-CVD causes, four 
records focused on CHD, one used CVD and one used IHD. Of the ten records in 
this section, six (60%) reported a negative relationship between placental weight and 
mortality and morbidity (i.e. a lighter placenta is associated with an increased 
mortality risk), three (30%) reported a positive relationship (i.e. a heavier placenta is 
associated with increased mortality risk) and one (10%), Martyn et al. (1996), had 
mixed results, reporting a negative relationship for stroke, and a positive relationship 
for CHD and for non-CVD related deaths. 
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Table 5. Results of literature search. Articles listed have reported both placental weights and an association with cardiovascular morbidity and 
mortality. Placental weight categories, measure of cardiovascular morbidity and mortality such as odds ratio (OR), hazard ratio (HR), 
standardised mortality ratio (SMR), risk ratio (RR), direction of relationship (positive trend denotes an increase in risk between lightest to 
heaviest placental weight categories and a negative denotes a decrease in risk between the lightest to heaviest placental weight categories), p-
values for linear trends are listed when available in the published article. In some cases, SD, R2 and 95% CI were available and this has been 
noted in the table below. Of the ten articles, three articles showed a positive relationship, six showed a negative relationship and Matryn et al. 
(1996) demonstrated a negative result for stroke but a positive result for coronary heart disease. 
Authors Placental Weight 
categories 
Measure (eg OR, HR, RR, SMR) Direction of 
relationship 
P-value for 
linear trend 
Other measures 
Eriksson 
et al. 
(2011)  
 
≤550g 
650g 
750g 
>750g 
HR for coronary heart disease 
1.2 
1.1 
1.3 
1.0 (ref) 
Negative 0.1 In men whose mother’s BMI 
was above the median, 
coronary heart disease was 
associated with low placental 
weight and small placental 
area. 
Barker 
et al. 
(2009) 
 
≤550g 
650g 
750g 
>750g 
OR for diagnosed hypertension 
1.8 
1.3 
1.3 
1.0 (ref) 
Negative <0.001 Diagnosed hypertension 
OR increased as placental 
weight, area and the two 
diameters decreased. 
Hypertension was associated 
with both reduced placental 
weight and with increased 
placental weight in relation to 
birth weight. 
Fan et 
al. 
(2009) 
 
 
 
 
 
<450g 
560g 
670g 
≥675g 
OR for coronary heart disease 
1.0 (ref) 
0.69 
0.5 
0.47 
Negative 0.05 Subjects with CHD had lower 
birth-weight, placental weight, 
birth length, smaller head 
circumference, and birth-
weight/length. 
Placental weights were low, 
17.8% weighed less than 450g 
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Eriksson 
et al. 
(2010) 
 
 
≤550g 
650g 
750g 
>750g 
OR for diagnosed hypertension Negative 0.06 (Men) 
 
<0.001 
(Women) 
OR per 100g 
0.89 (Men) 
0.80 (Women) 
Mean birth weight and 
placental weight were higher in 
boys. 
Hypertension in men was only 
weakly related to low placental 
weight. 
Women with low placental 
weight and area were at 
increased risk.  
Men 
1.6 
1.1 
1.2 
1.0 (ref) 
Women 
2.0 
1.6 
1.3 
1.0 
Risnes 
et al. 
(2009) 
 
Lowest - Median 
560g 
Middle - Median 
680g 
Highest - Median 
800g 
HR for cardiovascular disease 
 
1.0 (ref) 
 
0.97 
 
1.35 
Positive 
 
 
0.04 Birth weight included as a 
covariate in analysis of 
placental weight. 
Hesmati 
& Koupil 
(2014) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
≤550g 
650g 
750g 
>750g 
Rates per 100,000 for Ischaemic Heart 
Disease 
Negative for 
all categories. 
95% CI 
reported. 
Negative trend found for both 
men and women. 
4 multivariate models 
investigated 
Men 
1344 
1320 
1249 
1232 
Women 
799 
705 
711 
682 
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Eriksson 
et al. 
(2000) 
 
 
 
 
 
 
≤450g 
550g 
650g 
750g 
>750g 
 
Cumulative incidence (%) of hypertension 
(use of medication) 
  
Negative for 
all categories. 
0.07 (Men) 
 
0.91 
(Women) 
 
0.16 (All) 
No statistically significant trend 
with placental weight and 
cumulative incidence of 
hypertension. 
Men 
30.7 
28.8 
25.4 
27.0 
24.6 
Women 
28.3 
27.8 
28.5 
30.1 
27.3 
All 
29.5 
28.3 
26.9 
28.5 
25.8 
 
Forsen 
et al. 
(1997) 
 
≤500g 
600g 
700g 
>700g 
SMR for coronary heart disease 
111 
98 
76 
67 
 
 
Positive 0.004 Ponderal index was strongly 
associated with placental 
weight. Men who had a low 
placental weight had a low 
ponderal index at birth and 
raised death rates from 
coronary heart disease as 
adults. 
Forsen 
et al. 
(1999) 
 
 
≤500g 
600g 
700g 
>700g 
HR for coronary heart disease 
No data reported. 
Statement only  
Positive  Statement 
only 
Trend was 
not 
significant. 
Hazard ratios tended to rise 
with increasing placental 
weight, although this trend was 
not significant. There was, 
however, a significant rise with 
an increasing ratio of placental 
weight to birth weight (P=0.01, 
adjusted for gestation). In a 
simultaneous analysis with 
birth weight, placental weight, 
and gestational age the hazard 
ratios fell with increasing birth 
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weight (P=0.007) but rose with 
increasing placental weight 
(P=0.03). There were stronger 
trends in a simultaneous 
analysis of birth length, 
placental weight, and 
gestational age, the hazard 
ratios falling with increasing 
birth length (P>0.0001) and 
rising with increasing placental 
weight (P=0.02). The hazard 
ratios increased by 13.8% (7.5 
to 19.6) for each cm decrease 
in length at birth and increased 
by 14.8% (2.6 to 28.3) for each 
100 g increase in placental 
weight. The trends with length 
and placental weight were 
similar for fatal and non-fatal 
disease. 
Martyn 
et al. 
(1996) 
Placental weights 
in pounds 
(converted to 
grams) 
≤1.0 (≤454g) 
1.01-1.25 (458.54-
567.5) 
1.26-1.5 (572.04-
681) 
>1.5 (>681) 
 
 
SMR for stroke, CHD  and non-CVD causes Negative 
(Stroke) 
 
Positive 
(CHD) 
 
Positive (non-
CVD causes) 
Not stated. 
 
U shaped variation noted.  
5% of the population died from 
stroke, 35% died from 
coronary heart disease.  
Stroke 
 
 
147 
 
125 
 
96 
100 
CHD 
 
 
93 
 
108 
 
97 
106 
Non-CVD causes 
 
 
101 
 
103 
 
106 
103 
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3.5 Records With Defining Statements But No Data. 
There were four records found through the search which made defining statements 
on the relationship (or lack of) between placental weight and either blood pressure or 
death by IHD. Table 6 lists the four records along with key information such as the 
defining statement. One record reported no evidence of an association between 
placental weight and mortality from IHD and three records reported on the 
association between placental weight and blood pressure. Of the three records 
reporting associations with blood pressure, one indicated no consistent relationship 
between placental weight and SBP or DBP, another reported that the placental 
weight was not associated with SBP, but had a correlation with DBP (r=0.12, 
p=0.05). The last record reported that an inverse relationship between SBP and 
placental weight existed (p=0.003) after adjustment for age, sex and current weight 
and this became non-significant in a simultaneous regression with birth weight. 
Therefore, it was deemed non-significant.  
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Table 6. Results of literature search. Articles listed have not reported any data. 
Authors made a summary statement of the relationship in the text of the article. 
Authors Placental 
Weight 
Categories 
Measure 
used 
Statement 
Leon et 
al. 
(1998) 
Not 
reported 
Data not 
shown 
 
There was no evidence of any 
association of placental weight with 
mortality from ischaemic heart disease. 
Martyn 
et al. 
(1995) 
Not 
reported 
Data not 
shown 
SBP and 
DBP age 50-
53 yr 
No consistent relationship between adult 
blood pressure and placental weight or 
ponderal index (weight/length3) of the 
infant for either systolic or diastolic 
pressure found. 
Moore et 
al. 
(1999) 
Not 
reported 
Data not 
shown SBP 
DBP age 20 
yr 
Placental weight was not associated 
with systolic pressure when considered 
alone. 
Placental weight was correlated with 
DBP (r=-0.12, p=0.05) which did not 
persist after adjustment for gestational 
age. 
Forrester 
et al. 
(1996) 
Not 
reported 
Data not 
shown SBP 
age 6-16 
Placental weight was inversely related 
to systolic pressure after adjustment for 
age, sex, and current weight (test for 
trend p=0.003) This relationship became 
non-significant in a simultaneous 
regression with birth weight.  
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3.6 Characteristics of The Studies.  
To further investigate the nature of these studies a range of characteristics that may 
influence the findings have been explored. Figure 5 displays the various 
characteristics of the records included in this study. Note that a total of six records 
are not included in Figure 5, these include the four records reported in Table 6. The 
other two records do not appear in this figure because they were either a record that 
measured placental weights and only related it to exposure to famine (Roseboom et 
al., 2011) and a record which measured placental weights and used them in a cluster 
analysis of Percentage of Expected Birth Weight (Huang, et al., 2007) or did not 
explicitly report any data. 
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Figure 5. Different types of cardiovascular characteristics reported in the articles found. A score of 1 was allocated to each key measure e.g. a 
record that reported SBP and used a regression model would contribute a score of 1 to both the regression model and the SBP key measure.  
Note: the four records reported in Table 6 do not appear in this figure. 
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3.7 Age of Participants. 
The participants studied in the various records found ranged from 1 year to 69 years of age, Figure 6 graphs the range of ages, a score or 1 
was given to each age category reported e.g. if the record stated that the cohort was between 6 and 16 years of age, then a score of 1 was 
allocated to each year from 6 through to 16. Although the range was from 1 year to 69 years of age, there appears to be a gap in the data 
available for participants 21-36 years, where there were no studies with any participants in that age range.  
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Age of participants 
Figure 6. Age of participants in the 26 records identified.  
Note: A score of 1 was allocated to each age category reported in the record such that a record stated that the cohort was between 
6 and 16 years, a score of 1 was allocated to each year from 6 through to 16. 
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3.8 Geographical Focus 
A geographical analysis of the 26 records is displayed in Figure 7, as a heat map of the world.The records clustered around specific areas of 
the world, namely the United Kingdom (10 records), followed by Finland (5), Australia (4) and Sweden (2). China, India and Norway all had 1 
record each. The studies anaylsed in the meta-analysis focused on cohorts from the United Kingdom (Barker et al., 1990; Whincup et al., 1995) 
and Australia (Blake et al., 2001; Moore et al., 1996).   
 
Figure 7. Heat map displaying the locations of the 26 studies identified. 
Legend 
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4. Discussion. 
 
Cardiovascular diseases are the leading non-communicable cause of mortality 
world-wide. The early environment, particularly the intrauterine environment, has 
been implicated as a risk factor and a potential target for intervention. However, the 
role of the placenta in this relationship is poorly understood. 
This study used meta-analytical techniques to explore the association between 
placental weight and subsequent cardiovascular health outcomes in humans. The 
initial search process detailed in Figure 1 identified 844 records. Of these, 26 
records, providing 6 data points in total, were analysed. 
The systematic review identified 26 records which matched the selection criteria and 
these records had a combined cohort of 109,721 individuals, with 5,823 affected 
individuals. Four records reported compatible data that was adequate to perform a 
statistical meta-analysis (refer to Figure 4). Blake et al. (2001) reported data at age 
1, 3 and 6 years of age and so each data set was treated as an individual study, 
providing six data points in total. 
The meta-analysis showed that a lighter placenta was associated with a subsequent 
higher blood pressure. This association was greatly influenced by an outlier and 
once removed, the combined effect reversed direction to favour a heavier placenta. 
The only record which retained significance (p=0.034) was one of the original articles 
written by Barker et al. (1990). The remaining records displayed an effect which is 
not significant and very close to the line of no effect. This analysis suggests that the 
evidence relating specifically to placental weight and CVD is much more diverse than 
for birth weight. Currently a strong conclusion on the effect size cannot be made. 
Importantly, this analysis brings the placental weight research into focus and 
highlights methodological weakness, research gaps and future directions for study. 
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4.1 Inspection of Funnel Plots, Meta-Analysis Results and 
Outlier. 
On examination of the first funnel plot, (Figure 2) a clear indication of a publication 
bias related effect was noted, as there was a specific record (highlighted in red) 
which did not sit in the boundary of the funnel plot. This visual observation was 
supported by the Egger’s p-values of 0.01 (1-tailed) and 0.02 (2-tailed). The clear 
outlier was removed and the plot re-drawn, with the resulting plot (Figure 3) being 
more consistent with the type of plot that demonstrates symmetry, that is all the 
records are plotted within the confines of the funnel plot boundaries. This is further 
supported by Egger’s p-values<0.05 (0.011, 1-tailed and 0.022, 2-tailed) indicating 
that publication bias was evident. The outlying record (Whincup et al., 1995) had 
such a large impact on the funnel plot and combined effect size because its cohort 
size was the largest of the records in this calculation (n=1,511 compared to n=1,039 
for the next largest cohort) and therefore had more power in affecting combined 
effect size. Additionally, removing this outlier influenced the I2 score (increasing it 
from 55.5% to 99.4%) which firmly set it in the category of a mixed effects model as 
it was above the 75% threshold prescribed by Fernandez & Tran (2009). In the 
original meta-analysis, the outlier was seen to have an effect size of 4.125 compared 
to the combined effect of 0.250 (as calculated by the Standard Difference in Means 
in Table 2), which further highlights the magnitude of the effect of this specific record. 
To gain a better understanding of the quality and reliability of these findings, the 
effect of this outlier was investigated further using the NOS to examine and rank the 
records. The outlier returned a maximum score of nine out of nine stars, indicating 
that it was a high quality study. This score placed the outlier on par with a study by 
Risnes et al. (2009), which was the only other record to score nine stars.  
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Although the two studies measured different factors, Whincup et al. (1995) measured 
SBP and Risnes et al. (2009) measured mortality, it is useful to compare their 
findings. For Whincup et al. (1995) a heavier placenta was associated with a 
decrease in SBP whereas Risnes et al. (2009) found that a heavier placenta was 
associated with increased chance of death by CVD and CHD and a decreased 
chance of death by stroke and this further highlights to complications with studying 
the effect of placental weight on CVD, as increased SBP is noted as one of the risk 
factors for all CVD. 
Therefore, the high quality of the Whincup et al. (1995) article does support its 
inclusion in the meta-analysis. However, its influence on the direction of the 
combined effect and presence of publication bias indicate that there needs to be 
more exploration of the data as well as unified reporting of the research which will 
facilitate the inclusion of other studies into future meta-analyses.  
Moreover, this raises the issue of which additional articles that were excluded should 
be considered and contribute to the effect recorded. 
4.2 Placental Weight and Blood Pressure and Sex. 
Of the 12 records which examined placental weight and blood pressure, 5 reported a 
positive relationship for the entire cohort studied, indicating that as placental weight 
increased, so too did blood pressure (refer to Table 4 for further details). Four 
records reported a negative relationship for the entire cohort studied, two records 
split their cohorts into girls and boys and SBP and DBP. The remaining record 
(Barker, 1997) is not included as it referred to a cohort already studied (Barker, 
1992). 
Fundamental physiological differences between the sexes indicate that there is a 
need to examine the variation between sexes. Winder et al. (2011) and Taylor et al. 
(1997) split their cohorts into girls and boys and measured both SBP and DBP. 
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Winder et al. (2011) reported means and SD whereas Taylor et al. (1997) performed 
regression modelling. Winder et al. (2011) identified a negative trend for boys (both 
SBP and DBP) with the boys DBP being significant (p-value=0.02) and a negative 
trend for girls SBP which was not significant (no p-value reported). Taylor et al. 
(1997) identified a negative trend for girls (SBP and DBP) with only the girls SBP 
trend being significant (p-value=0.01) and a positive trend for boys (SBP and DBP) 
with only the boys (DBP) trend being significant (p-value=0.05). This variation 
between males and females has been attributed to key differences in hormone 
profiles, as demonstrated by experiments on IUGR rats where males showed 
significantly higher blood pressures compared to the female IUGR rats (Dasinger & 
Alexander, 2016). Here oestrogen is seen as a protective factor, which normalises 
blood pressure and provides protection for females from CVD, conversely, the male 
hormone, testosterone is seen as a cause for elevated blood pressure (Dasinger & 
Alexander, 2016). This is reflected in the human population where men usually 
display higher blood pressures and greater risk for CVDs than women of the same 
age (Dasinger & Alexander, 2016; WHO, 2011). Therefore a separate analysis for 
males and females may be necessary to clarify the relationship and may cancel each 
other out in studies that are included in the current meta-analysis. 
Two of the most influential articles in the field of DOHaD which have been key 
references in the formation of this paradigm observed cohorts of adult age: Barker et 
al. (1990) and Barker et al. (1992). Barker et al. (1990), examined the Relative Risk 
(RR) of having a SBP greater than 160mm Hg and the RR of being treated for 
hypertension in doing so. The authors noted that SBP and DBP were strongly related 
to placental weight and that the highest pressures were measured in people who had 
been small babies with large placentae and conversely, the lowest pressures were 
measured in people who were large babies with small placentae (Barker et al., 
1990). The second record, Barker et al. (1992), similarly found a positive trend with 
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mean SBP and placental weight although no significance measure was reported. 
The Barker et al. (1990) article noted that babies with placentae >1.5 pounds or 
>681 grams (SI unit conversion 1 pound = 454g) had a greater RR of having a SBP 
>160 mm Hg as well as a greater RR of being treated for hypertension than babies 
with a placental weight of ≤1.5 pounds. In further support the Barker (1992) article 
reported that babies with placental weights >1.5 pounds or >681 grams had higher 
mean SBP in adult life. This further highlights the complexity of the relationship, 
although, placental characteristics such as size, weight, volume and shape are all 
factors in determining the efficiency of a placenta. Ultimately, it is the amount of fetus 
which develops from a placenta that is the evidence of the efficiency of a placenta. 
Thus it may be inappropriate to consider placental weight as a predictor of CVD in 
isolation and it is its relationship with birth weight that provides more information. 
However, although the placental weight to birth weight ratio may in turn be limited, it 
is possible that a heavy placenta may be just as efficient as one of less weight 
simply because it has the same surface area (Salafia et al., 2008; Eriksson et al., 
2011).     
4.3 Placental Weight and CVD, CHD, IHD and Stroke. 
Of the 10 records which examined the risk of developing or dying from CVD, CHD, 
IHD and Stroke, six (60%) reported that a heavier placenta was associated with a 
decreased chance of death. Of these six records, two reported that the linear trend 
was significant, one reported that it was significant only for women, three records 
reported a positive association and two indicated that it was significant. The last 
record by Martyn et al. (1996) split the cohort into three groups, a stroke group, a 
CHD group and a non-CVD group and they reported that a heavier placenta 
decreased the risk of stroke, but increased the risk of death by CHD and non-CVD 
causes. No p-values or any other measures of significance were reported although a 
U-shaped variation was observed in this study (Martyn et al., 1996). 
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When these studies are grouped by disease (e.g. diagnosed hypertension, CVD, 
CHD, IHD), there were no consistent findings. The majority of the studies reported a 
significant p-value for linear trend, however the direction of the relationship was 
almost evenly divided between studies showing that a heavier placenta is associated 
with decreased risk and a lighter placenta associated with increased risk.   
4.4 Variation, Study Characteristics and Measured Outcomes. 
It has been noted by the PRISMA group (2009) that variation in reporting does have 
a negative impact on the usefulness of systematic reviews and meta-analyses. This 
statement is clearly supported by the findings from the current study. In the 26 
records identified, substantial variation has been apparent in the different methods of 
reporting. Figure 5 highlights the numerous items reported including odds ratios, 
hazard ratios and standardised mortality ratios. As well as the methods of measuring 
placental weight, one record indicated that the placentae were fixed in formalin 
(Whincup et al., 1999) compared to the other studies in which placentae are 
measured in an unfixed state. 
Outcomes (conditions) are also measured in different ways where some report only 
the SBP while others used a diagnosis of hypertension, or treatment for CVD and 
others only looked at mortality rates. Further to this variability there is the rate of 
survival from a major CVD incident (e.g. myocardial infarction or stroke) or receiving 
treatment.  
In addition to these variations, there are physiological and anatomical variations of 
the placenta, which is an organ that grows with the fetus and adjusts its growth 
patterns to match the environment as well as the demands from the fetus. Variations 
in the placenta can be affected by the environment through infections, anatomical 
differences in the point of attachment on the uterine surface as well as the level of 
remodelling of the spiral arteries. As the fetus develops, its nutritional demands are 
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served through the placenta and this is maintained via a delicate balance between 
growth of the fetus and growth of the placenta. Additionally, the fetal heart and the 
placenta share common developmental requirements, such as common genes and 
micronutrients (e.g. folate) regulating essential developmental steps (Burton & 
Jauniaux, 2018). Considering these factors, no two placentae should be alike, 
therefore, it is all the more important to systematically select and process placental 
measures in the future to standardise this field (Salafia & Roberts, 2019). 
A key difference in the reporting and comparison of placental weights is the weight 
categories used by researchers. In summary, across all the records found, there was 
a broad range in the placental weights studied with the lightest placental weight 
group being ≤350g and the heaviest >750g (there was another study reporting the 
highest group with a median placental weight of 800g). To further complicate 
matters, Barker et al.’s (1986, 1990, 1993) earlier work utilised imperial pounds as 
the standard measure and the lightest placental weight group was ≤1 pound or 
≤454g and the heaviest group was >1.5 pounds or >681 grams (SI unit conversion 1 
pound = 454g). 
The cohorts studied were regularly divided into groups according to placental weight. 
Aside from the four records which made defining statements and the four records 
which used regression modelling, all other records (18), divided the cohorts into 
groups according to placental weight. The number of groups ranged from three to 
five with the most common being four groups (13 records). Of these 13 records that 
used 4 placental weight categories, the largest placental weight group was >750g 
and the smallest was ≤550g. Only one record used 5 placental weight groups, in this 
record, a ≤450g group was added to accommodate the lightest placentae in that 
study. Only one record reported median placental weight for the groupings and there 
were three groups in this record (Lowest group: median placental weight 560g; 
Middle group: median placental weight 680g; Highest group: median placental 
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weight 800g). The variety in these categories impacted on the ability to find 
comparable data to carry out a comprehensive meta-analysis. A more uniform 
reporting of this data would improve the comparability of the data for meta-analysis. 
Alternatively, if raw data sets were obtained, it may be possible to perform meta-
regression analysis on these data sets as a whole in a similar way that Gamborg et 
al. (2007) used birth weights and systolic blood pressures from 20 Nordic studies. 
This variance in placental weights, particularly the proportion of low weight 
placentae, was noted by Fan et al. (2009) as 17.8% of all placentae in their study 
(total n=2033) weighed less than 450g. More strikingly, Winder et al. (2011) studied 
a cohort where 74.9% of all placentae weighed less than 450g (total n=471). By 
contrast, Eriksson et al. (2000) reported figures showing only 7.2% of placentae in 
the same weight category (total n=7086). Exploring the mean weights of placentae, 
we find that in Fan et al. (2009) the mean placental weights were 539.1g ± 103.1g 
(n=928 men) and 525.7g ± 101.8g (n=953 women). Winder et al. (2011) reported 
mean placental weights for boys (n=228) of 410g (SD=81g) and 407g (SD=85g) for 
girls (n=243). At the opposing end of the scale, Forsen et al. (1997) reported the 
heaviest mean placental weight of 634g (SD=128g) and a placental weight range for 
men from 240g to 1440g (n=3302). Comparably, a study of 513 placentae found a 
mean placental weight (trimmed) of 538.3g (SD=95.3g) which was closer to Fan et 
al.’s (2009) cohort and a range of 261g to 877g (Coall et al., 2009). 
In addition, the methodology used to weigh the placentae can make significant 
differences. Due to a range of factors, there has been measurement errors in the 
past, and even in the current research, uniform weighing of placentae within and 
between studies were not present, a key factor influencing placental weight being the 
time from birth to weighing of the placenta. (Coall et al., 2009).   
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It can be seen that extremes of placental weight exist in the various cohorts studied 
and unlike birth weight where 2.5 kg is seen as a critical cut off, there is no cut off for 
placental weight. Records which attempted to evenly distribute the cohort into groups 
were required to make arbitrary decisions on the groupings based on no defining 
evidence on what an adequate weight for a placenta is. This lends weight to the 
notion that placental weight cannot be used in isolation when examining its effects 
on cardiovascular outcomes of the baby until standardised advances in methodology 
have been agreed upon. Further investigation into what a ‘standard placenta’ is and 
a better understanding of what placental weight represents is essential for this 
research to progress.       
4.5 Age of Participants. 
As shown in Figure 5, the age range of participants was from 1 to 69 years old. 
There was, however, a gap between 21 and 36 years of age where there were no 
records found focusing on people of that age. It is understood that there is a paucity 
of information in that age bracket as it is an age group in which CVD is not seen as a 
major risk and deaths caused by CVD are rare and usually attributed to unusual 
circumstances. Likewise, hypertension and blood pressure in general is not a key 
concern for people in that age group and so it is not a widely studied factor. When 
considering age, it is also important to consider that the protective nature of 
oestrogen does diminish as women reach menopause and oestrogen production 
slows (Dasinger & Alexander, 2016). This variation and the underlying assumptions 
related to the relatively healthy age group may contribute to a lack of research in this 
age group. 
4.6  Geographical Focus 
When the records were compared according to country of focus, it was found that 
38.5% (n=10) of the records focused on cohorts in the United Kingdom, followed by 
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19.2% (n=5) for Finland, 15.4% (n=4) for Australia, followed by 7.7% (n=2) for both 
Sweden and the West Indies (Jamaica), and 3.8% (n=1) for China, Norway and 
India. It is important to note that although Norway had one record, it was the largest 
of all the cohorts studied (n=31,307). 
The most prolific author was Barker, who appeared in 12 records (46.2%), six 
focusing on cohorts in the United Kingdom, all of the five records focusing on Finland 
and the one record that focused on India.   
4.7 NOS Analysis of Quality. 
As the present study was not able to complete a comprehensive meta-analysis of the 
records identified, it was recognised that a tool to assess the quality of the articles 
should be employed to further investigate these results. The NOS scale was used to 
provide further analysis of the quality of the records found as it was previously used 
to investigate the outlier which was ranked the equal highest with the maximum 
score (nine stars). The remaining records in the meta-analysis scored eight stars 
(Barker et al., 1990) and six stars (Blake et al., 2001) and (Moore et al., 1996). This 
indicates that the studies included in the meta-analysis were of Good quality.   
Further analysis of the records showed that the mode and median score were both 
seven stars and the mean was 6.9 stars (SD 1.1) with the range of scores from five 
to nine stars. There were three records scoring the lowest (five stars) which 
according to the AHRQ is a fair quality study. These articles were lacking in the 
‘Selection’ domain under the “Representativeness of the Cohort” as they were 
subsets of larger cohorts such as in the Winder et al. (2011) study in which eligible 
participants attended the antenatal clinic at the Holdsworth Memorial Hospital in 
Mysore, South India and they didn’t have diabetes before pregnancy. In addition, 
there was a 67% uptake by the eligible parties. Likewise, Moore et al. (1999) focused 
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on the cohort born at a single (unnamed) hospital in Adelaide, South Australia, 
furthermore, there was a 72% participation rate.  
The ‘Outcome’ domain was another domain in which these records scored poorly 
(scoring one out of a possible 3 stars). It is noted that the adequacy of follow up may 
be a reflection of low participation rates as other studies with higher participation 
rates scored better in this domain. Finally, in the ‘Comparability’ domain, these three 
records failed to satisfy the criteria “Adjustment for age, sex and marital status”, 
which was not a key issue as only three records were able to satisfy this. 
The ‘Outcome’ domain was the domain which saw the greatest variability with the 
highest ranked records achieving a full 3✯ and the lowest ranked records achieving 
1 out of 3✯, which was due to the impact of lower levels of follow up rates. Despite 
this the records achieved a mean of 6.9✯ (SD1.1), which indicates how important 
complete and accurate data recording, as well as good follow up practices are, when 
conducting this research as those three articles ranked as Fair quality, would have 
been ranked as Good if the follow up rates were improved. All ten articles reporting 
rates of mortality and morbidity due to CVD were ranked in the Good category, and 
although 60% of the articles found a negative association, there was one record 
(Risnes et al., 2009) scoring the highest possible score of nine stars which found a 
positive trend. To further highlight the inconsistencies, for the articles reporting on 
blood pressure and hypertension, the highest ranked article (Whincup et al., 1995) 
reported a negative association.     
4.8  U shaped curve 
A possible explanation of the inconsistent nature of the findings may be due to the 
assumption made about the data and data analysis. It is evident that most articles 
assume the association between measures of the uterine environment such as 
placental weight and cardiovascular health is linear. However, because of the 
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adaptive reserve capacity of the placenta, there is no reason to assume an 
increasing placental weight is uniformly positive or negative. Therefore, it is 
important to explore curvilinear, particularly quadrilateral relationships. 
Theoretically, the u-shaped curve association between the early environment and 
cardio-vascular health is likely to exist. In a study of 15,324 children, where SBP was 
measured, both the lower birth weight group (<2,000 g) and the higher birth weight 
group (3,500–3,999 g) and the highest birth weight group (>4,000 g) exhibited 
significantly higher SBP when compared to the median weight group (2500–2999 g) 
(Lai et al., 2019). The median birth weight group had the lowest SBP (103.56±0.23 
mm Hg) and was set as the reference group, the lower birth weight group had a 
mean SBP of 106.00±0.72 mm Hg (p=0.017), and the higher birth weight group had 
a mean SBP of 105.13±0.17 mm Hg (p<0.001). The highest group exhibited a mean 
SBP of 105.96±0.27 mm Hg (p<0.001).  
Moreover, there are recognised differences in male and female physiology which 
indicate that the association in males could be different to that in females. In a study 
using linear regression modelling, placental weight was shown to have a negative 
association in girls and a positive association in boys for both SBP and DBP, 
furthermore, the p values for differences in the regression coefficients (b) were see 
to be significant (p=0.002 for SBP and p=0.05 for DBP) (Taylor et al., 1997). 
However, the majority of studies found through this meta-analysis fail to examine or 
do not report looking for this u-shaped relationship between placental weight and 
CVD.  
In Thornburg et al.’s (2010) review of the placenta’s role in programming subsequent 
cardiovascular disease, a U-shaped relationship was said to exist between the 
placental to fetal weight ratio and CVD. In the present study, one record, reported a 
U-shaped variation when describing the association between placental weight ratio 
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and risk of CVD (Martyn et al., 1996). Therefore, both a low and high placental 
weight ratio are associated with an increased risk of CVD. Consequently, the risk 
factor may not be the absolute birth weight or placental weight but the relative 
weight. This may more accurately reflect the challenges of the early environment and 
the placenta’s capacity to adapt to insults. The placenta can adapt morphologically 
and functionally and these adaptations are a response to meet the demands of the 
developing fetus (Sferruzzi-Perri & Camm, 2016). These changes may be seen in 
changes to endothelial function, growth factors and angiogenesis that are then 
related to CV health. This provides strong evidence that the growth regulating 
abilities of the placenta may lead to reduced cardiovascular health in the offspring. 
Therefore, future research and secondary data analysis should routinely explore the 
curvilinear, in addition to the linear, associations between the early environment and 
adult outcomes. Ultimately, this will advance the field and align the epidemiological 
associations with the underlying biological evidence. 
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5. Conclusion. 
 
This study, through the meta-analysis of data points, found that a higher blood 
pressure was associated with a lighter placenta (a combined effect of 0.25 with a p-
value <0.05). Due to the presence of an outlier, the analysis was repeated without 
the outlier and the combined effect indicated that a higher blood pressure was 
associated with a heavier placenta (combined effect of -0.044) but this was not 
significant (p-value=0.24).  
Through this process of systematically searching the literature and conducting a 
meta-analysis, it has been shown that a large study such as that by Whincup et al. 
(1995) can alter the results of a meta-analysis greatly. The findings from this project 
further demonstrate the complexity of the field of study. There is a plethora of 
variation including study designs, measured outcomes and reporting criteria which 
may obfuscate the possible trends and observations. Further to this, the variety of 
confounding variables which a study can adjust for demonstrates that placental 
weight cannot be viewed in isolation. The field has moved towards more complex 
measures of the placenta such as thickness, circumference and volume. 
Furthermore, real time imaging of the placenta in-utero, as the fetus develops, will 
contribute another dimension to our understanding. 
Future studies require standardised reporting of variables and measured outcomes 
as well as methodologies (e.g. standardised weighing of the placenta and reporting 
of weight categories). It is also recommended that retrospectively, raw data should 
be shared enabling the categorisation of variables to be matched and a large, more 
accurate and inclusive meta-analysis may be conducted. There is a need for 
uniformity in the data collection and analysis to enable a deeper understanding of the 
association between the early environment, particularly placental measurements, 
and the subsequent risk of adult disease.   
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In addition, future studies should attempt to capture the missing age groups (21 – 36 
years of age) and include them in the analysis of the effect of placental weight on 
cardiovascular outcomes, this would further contribute to the field of research. 
6. Limitations. 
 
The author notes that the search concluded in 2017 and it has taken 17 months to 
complete this thesis, therefore, it is possible that articles published after 2017 were 
not included in this work. This was unavoidable, due to the nature of the full time 
work commitments of the author. To the best of my knowledge no pertinent research 
is available to include. However, it may be possible in future studies to redo the 
search with stricter time limits and using an independent searcher to verify the 
findings. 
The systematic literature search itself was conducted by the author alone and it has 
been recommended by the PRISMA group as well as the Cochrane group that 
searches should be conducted in tandem at least for reliability. Information 
technologists at the ECU library were contacted to assist and while their advice was 
valuable, it was clear that it was an important factor, however, limited resources and 
capabilities meant that this was not possible. As with all systematic reviews and 
meta-analyses, the grey literature is a limitation. Every effort was made to search for 
grey literature and to contact likely authors who had published related work, 
however, communications to the corresponding authors were not successful. 
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8. Appendix A Extracted Data From Records  
Source 
Setting/Cohort 
Studied 
Recruitment 
Location 
Method of 
Measurement 
Diagnostic 
Criteria For 
Cardiovascular 
Disease 
Age at 
Outcome 
(Years) 
Total Number 
of Subjects 
(Number of 
subjects with 
Cardiovascular 
Effects)  
Placental 
weight 
categories 
(if 
reported) 
Other placenta 
data 
Key findings 
related to 
placenta Comments 
Eriksson, Kajantie, 
Thornburg, 
Osmond & Barker. 
(2011) Mother's 
body size and 
placental size 
predict coronary 
heart disease in 
men. European 
Heart Journal 
32:2297-2303 
Men Helsinki 
Cohort, 1934-44 
Details of birth 
records from 
University Central 
Hospital or the 
Maternity 
Hospital in 
Helsinki 
Historical Medical 
Records                                   
HR (95% CI) 
Death classified by 
International 
Classification of 
Disease (ICD) 
codes. 
Not reported. 
Data reports 
death or 
hospital 
admission due 
to coronary 
heart disease 
(ICD-8, ICD-9 
and ICD-10). 6975(655) 
≤0.55kg                                     
0.65kg                          
0.75kg                               
>0.75kg  
Placental surface area              
Placental/birth 
weight (%)                      
Placental length 
minus breadth 
Three combinations 
of maternal body size 
and placental size 
predict later coronary 
disease in men. 1) 
Oval placental 
surface in short 
mothers, 2) small 
placental surface in 
tall mothers whose 
body mass index was 
above the median. 3) 
Large placental 
surface in relation to 
birth weight.                                                               
Men whose mother's 
BMI was above the 
median, coronary 
heart disease was 
associated with low 
placental weight and 
small placental area. 
HR 1.25 (1.10-1.42, 
P=0.0007) per 40 
sqcm decrease in the 
surface area.                                                 
Men whose mother's 
BMI was below the 
median coronary 
heart disease was 
related to a high ratio 
of placental weight 
to birth weight and a 
high ratio of 
placental area to 
1934-44
Helsinki Cohort                            
Women were 
excluded from 
the analysis as 
only 166 cases 
of coronary 
heart disease 
were reported 
in the cohort. 
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birth weight (p=0.02) 
HR 1.07 (1.02-1.13, 
P=0.01) per 1% 
increase in the 
placental 
weight/birth weight 
ratio. 
Winder, 
Krishnaveni, Hill, 
Karat, Fall, Veena 
& Barker. (2010) 
Placental 
programming of 
blood pressure in 
Indian children. 
Acta Paediatrica 
100; 653-660 
Mysore Parthenon 
Cohort est. 1997 
Recruited from 
Holdsworth 
Memorial 
Hospital, Mysore, 
South India. 
Annual follow up 
(birth to 5 yr) and 
every 6 months 
therafter.                                    
Mean and SD 
reported 
Diastolic and 
Systolic blood 
pressure at age 9.5 
years. 9.5 years 471 
≤0.35kg                                     
0.4kg                          
0.45kg                               
>0.45kg  
Placental surface area              
Placental/birth weight 
(%)                              
Area/birth weight 
Three different 
placental phenotypes 
predicted raised 
blood pressure 
depending on the 
child’s sex and the 
mother’s height. 
Common to each 
phenotype was that 
blood pressure was 
related to the shape 
or size of the 
placental surface and 
to the breadth rather 
than to the length. 
Focus is on 
placental 
surface area 
and length vs 
breadth. 3 
Placental 
phenotypes. 
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Heshmati & 
Koupil. (2014) 
Placental weight 
and foetal growth 
rate as predicators 
of ischaemic heart 
disease in a 
Swedish cohort 
Journal of 
Developmental 
Origins of Health 
and Disease 5(3): 
164-170  
Uppsala Birth 
Cohort 
Multigenerational 
Study (UBCoS 
Multigen), 1915-
1929. 
Historical Medical 
Records from 
Uppsala 
University 
Hospital, Sweden. 
Historical Medical 
Records                                   
HR (95% CI) 
First recorded 
hospitalization or 
death from IHD, 
using International 
Classification of 
Disease (ICD) 
codes. 
Not reported. 
Data reports 
death or 
hospital 
admission due 
to coronary 
heart disease 
(ICD-7, ICD-8, 
ICD-9 and ICD-
10). 10503 
≤0.55kg                                     
0.551-0.65kg                         
0.651-0.75kg                               
>0.75kg  
Placental/birth weight 
(%) 
Negative linear trend 
was observed 
between placental 
weight and IHD after 
adjustment for birth 
cohort, age, sex and 
parity, and the 
association appeared 
to be mediated by 
fetal growth rate.                                         
In the analysis 
stratified by social 
class at birth, a 
negative association 
between placental 
weight and IHD was 
observed among 
individuals from 
medium social class 
after adjustment for 
birth cohort, age and 
sex. Similarly, a 
negative association 
between placental 
weight and IHD was 
found for individuals 
who had a low 
education. 
Placenta/birth weight 
ratio showed no 
evidence of a 
significant association 
with IHD in our 
cohort.  
Barker, 
Thornburg, 
Osmond, Kajantie 
& Eriksson. (2010) 
Subset of Helsinki 
Cohort (Men and 
Women) 1934-44.  
University Central 
Hospital and 
infant welfare 
clinics in the city. 
Historical Medical 
Records                                   
OR (95% CI) 
Diagnosed with 
hypertension and 
been prescribed 
medication. Not reported 2003(644) 
≤0.55kg                                     
0.65kg                          
0.75kg                               
>0.75kg  
Placental surface 
area. Maximal and 
lesser diameters 
Hypertension was 
associated with both 
reduced placental 
weight and with 
increased placental 
weight in relation to 
birth weight. Both of 
these associations 
have been found 
before (Barker et al, 
1990; Campbell et al, 
1996; Eriksson et al, 
2000). The 
association with low 
placental weight was  
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accompanied by 
reduced placental 
area but not reduced 
thickness. 
Risnes, 
Romundstad, 
Nilsen, Esklid & 
Vatten. 
(2009)Placental 
Weight Relative to 
Birth Weight and 
Long-term 
Cardiovascular 
Mortality: 
Findings From a 
Cohort of 31,307 
Men and Women. 
Am. J Epi 
170(5)622-631 
Trondheim Cohort 
1934-59  
St Olav's 
University 
Hospital 
Trondheim 
Norway. 
Historical Medical 
Records HR (95% 
CI) 
Death classified by 
International 
Classification of 
Disease (ICD) 
codes. 
Cardiovascular 
disease, coronary 
heart disease and 
stroke 
Mean age of 
mortality 51.3 
yr 31307(382) 
Low Med 
and High  
Placental/birth 
weight (%) 
A disproportionately 
large placenta 
relative to birth 
weight was 
associated with 
increased risk of 
cardiovascular 
disease death.  
Burke, Beilin, 
Blake, Doherty, 
Kendall, 
Newnham, 
Landau & Stanley. 
(2004) Indicators 
of Fetal Growth 
Do Not 
Independently 
Predict Blood 
Pressure in 8-
Year-Old 
Australians 
Hypertension 
43:208-213 Raine Cohort 1989 
King Edward 
Memorial 
Hospital, Perth, 
Western 
Australia. 
Historical Medical 
Records 
Regression 
coefficient R2  
Systolic Blood 
Pressure age 8 yr. 8 yr. 1417 Not Used 
Birthweght:placental 
weight. 
BW/PW ratio 
significantly greater 
in boys. No 
significance found in 
neonatal 
measurements and 
SBP. 
Study focused 
on BW and SBP, 
PW and BW:PW 
ratio were only 
considered in a 
regression 
model.  
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Whincup, Bredow, 
Payne, Sadler. 
Golding and the 
ALSPAC Study 
Team (1999) Size 
at birth and blood 
pressure at 3 
years of Age The 
Avon Longitudinal 
study of 
Pregnancy and 
Childhood 
(ALSPAC) Am J 
Epidemiol 
149(8):730-739  
Avon, England 
1991-1992 
Avon, Southwest 
Regional Health 
Authority 10% 
random sample 
from June 6 to 
December 11, 
1992.  
Historic Medical 
Records and 
longitudinal study 
with follow up 
every 4 months 
for first year and 
the every 6 
months. 
Regression 
coefficient and SE 
with p-value for 
trend SBP and DBP 3 660 Not used 
Placental 
weight/Birth weight 
ratio 
Placental weight 
showed to have a 
weak inverse relation 
with blood pressure. 
Which disappeared 
after inclusion of 
birth weight. 
Placental ratio also 
showed no relation 
with blood pressure 
No data 
supplied only 
regression 
coefficients. 
Placenta were 
fixed in 
formalin prior 
to weighing. 
Barker (1997) 
Fetal nutrition 
and 
cardiovascular 
disease in later 
life British Medical 
Bulletin 53(1):96-
108  
Summary article 
containing data 
from Preston 
cohort N/A Mean SBP  46-54 years    
At any given birth 
weight, SBP rose as 
placental weight 
increased. 
Sacrificing fetal 
growth for 
placental 
growth. 
Blake, Gurrin, 
Beilin, Stanley, 
Landau & 
Newnham. (2001) 
Placental weight 
and placental 
ration as 
predictors of later 
blood pressure in 
childhood Journal 
of Hypertension 
19:697-702 
Raine Cohort 1989-
1992 
King Edward 
Memorial 
Hospital, Perth, 
Western 
Australia. 
Prospective 
cohort study 
mean BP with 
95% CI 
Systolic Blood 
Pressure age 1, 3 
and 6 yr. 
Follow up at 1, 
3 and 6 years 
Age 1  - 964                   
Age 2 - 869                   
Age 3 - 1039 
≤0.54kg                                     
0.64kg                          
>0.64kg   
Inverse relationships 
existed between both 
systolic and diastolic 
blood pressure and 
placental weight, 
adjusted for current 
weight at ages 1, 3 
and 6 years. The 
relationships 
between placental 
weight and systolic 
blood pressure were 
statistically 
significant at ages 1 
and 3 years. There 
was no consistent 
relationship between 
placental weight and 
later blood pressure 
within birth weight 
categories. No 
clinically or 
statistically 
significant 
association was seen 
between the  
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placental ratio and 
either systolic or 
diastolic blood 
pressures at any age. 
Law, Barker, Bull 
& Osmond. (1991) 
Maternal and 
fetal influences on 
blood pressure 
Archives of 
Disease in 
Childhood 
66:1291-1295 
Salisbury Health 
District, UK. 1984-
85 
Hospital births in 
Salisbury Health 
District 
Historical Medical 
Records. Mean 
Difference (95% 
CI) BP 4 yr 405 
≤0.55kg                                     
0.65kg                          
0.75kg                               
>0.75kg  None reported 
BP rose with 
placental weight. 
Children whose 
placental weights 
were greater than 
750g, had average 
pressures of 2.6mm 
Hg (95% CI -0.8 to 
6.0) above those 
whose placental 
weights were 550g or 
less.  
102 
 
Barker, Bull, 
Osmond & 
Simmonds. 
(1990)Fetal and 
placental size and 
risk of 
hypertension in 
adult life BMJ 
301:259-62 
Preston, 
Lancashire, UK. 
1935-43 
Sharoe Green 
Hospital Preston, 
Lancashire. 
Historical Medical 
Records. Mean 
Difference (95% 
CI) 
BP and treatment 
for hypertension. 46-54 yr 449(124) 
In Pounds 
(lb)                     
≤1.0              
1.25                  
1.5               
>1.5                                
Converted to 
kg                        
≤0.45kg                    
0.57                 
0.68                     
>0.68 None reported 
The highest pressures 
were among people 
who had been small 
babies with large 
placentae and the 
lowest were among 
people who had been 
large babies with 
small placentae. 
Systolic and 
diastolic blood 
pressures were 
strongly related 
to placental 
weight. 
Moore, Miller, 
Boulton, 
Cockington, Craig, 
Magarey & 
Robinson. (1996) 
Placental weight, 
birth 
measurements, 
and blood 
pressure at age 8 
years. Archives of 
Disease in 
Childhood 
1996,74:538-541. 
Adelaide, South 
Australia. 1975-76 
Queen Victoria 
Hospital, 
Adelaide, South 
Australia 
Historical Medical 
Records Mean SD BP 8 yr. 830 
≤500g                 
501-600g          
>600g  
Placental weight 
alone was not related 
to systolic BP. There 
was a positive but 
not statistically 
significant 
relationship between 
placental weight and 
diastolic BP. 
At any birth 
weight BP 
tended to rise 
with increasing 
placental 
weight. At any 
placental 
weight BP 
tended to fall 
with increasing 
birth weight. 
Moore, 
Cockington, Ryan 
& Robinson. 
(1999) The 
relationship 
between birth 
weight and blood 
pressure amplifies 
from childhood to 
adulthood. 
Journal of 
Hypertension 
17:883-888 
Follow up of 
Adelaide cohort 
Queen Victoria 
Hospital, 
Adelaide, South 
Australia 
Longitudinal 
study correlation 
r SBP DBP 20 years 584  None reported 
Placental weight 
alone was not related 
to systolic BP. A 
positive association 
with the ratio of 
placental weight to 
birth weight was 
seen, this was 
diminished on 
adjustment for 
gestational age. 
Correlation with 
placental weight was 
seen but did not 
persist after  
103 
 
adjustment for 
gestational age.  
Forrester, Wilks, 
Bennett, Simeon, 
Osmond, Allen, 
Ching & Scott 
(1996) Fetal 
growth and 
cardiovascular risk 
factors in 
Jamaican 
schoolchildren 
BMJ 312:156-160 
Kingston, Jamaica, 
West Indies nd. 
University 
Hospital of the 
West Indies, 
Kingston, 
Jamaica. 27 
surrounding 
schools. 
Historical Medical 
Records and 
follow up SBP 6-16 years 1610 Not reported None reported 
Placental weight was 
inversely related to 
systolic pressure 
after adjustment for 
age, sex, and current 
weight (test for trend 
p=0.003) There was 
no significant relation 
between the ratio of 
placental to birth 
weights and blood 
pressure. 
No data on 
placenta 
reported. Only 
defining 
statement. 
Forsen, Eriksson, 
Tuomilehto, 
Osmond & Barker. 
(1999) Growth in- 
utero and during 
childhood among 
women who 
develop coronary 
heart disease: 
longitudinal study. 
BMJ 
1999;319:1403-7 
Helsinki, Finland 
1924-33 Women 
Helsinki 
University Central 
Hospital, Finland. 
Historic Medical 
Records HR 
Hospital admission 
for or death from 
coronary heart 
disease.  Not reported 3447 
500g                    
600g                    
700g                    
>700g 
Placental 
weight/Birth weight 
ratio 
Hazard ratios tended 
to rise with 
increasing placental 
weight although this 
trend was not 
significant.                                                
There was a 
significant rise with 
an increasing ratio of 
placental weight to 
birth weight (P=0.01, 
adjusted for 
gestation)                                                    
Trends for fatal and 
non-fatal disease 
were similar. 
HR trends seen 
in simultaneous 
analysis 
between 
placental 
weight, birth 
length, birth 
weight, 
gestational age.   
Forsen, Eriksson, 
Tuomilehto, 
Teramo, Osmond 
& Barker. (1997) 
Mother's weight 
in pregnancy and 
coronary heart 
disease in a 
cohort of Finnish 
men: follow up 
Helsinki, Finland 
1924-33 Men 
Helsinki 
University Central 
Hospital, Finland. 
Historic Medical 
Records SMR 
Death by ICD code 
8 or 9 
mean age of 
death 57 years 
(range 37-70) 3302(286) 
500g                    
600g                    
700g                    
>700g None reported 
Ponderal index was 
strongly related to 
placental weight, 
mean with low 
placental weight had 
low ponderal index at 
birth and raised 
death rates from 
coronary heart 
disease as adults.  
placental 
weight not 
investigated 
directly. 
104 
 
study BMJ 
315:837-40 
Eriksson, Forsen, 
Tuomilehto, 
Osmond & Barker. 
(2000) Fetal and 
Childhood Growth 
and Hypertension 
in Adult Life 
Hypertension 
36:790-794 
Helsinki, Finland 
1924-1933 still 
resident in Helsinki 
in 1971 
Helsinki 
University Central 
Hospital, Finland. 
Historic Medical 
Records p value 
for trend 
cumulative 
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maternal recall. 
105 
 
Campbell, Hall, 
Barker, Cross, 
Shiell and 
Godfrey. (1996) 
Diet in pregnancy 
and the 
offspring's blood 
pressure 40 years 
later. British 
Journal of 
Obstetrics and 
Gynaecology 
103:273-280 
Aberdeen, 
Scotland. 1948-54 
Aberdeen 
Maternity 
Hospital 
Historic Medical 
Records. 
Longitudinal 
Regression 
Coefficient and 
95% CI SBP DBP 
Mean age 40.6 
yr 253 Not used None reported 
Placental weight was 
positively correlated 
with mother's weight 
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0.75kg                               
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9. Appendix B NOS Quality Assessment Form for Cohort 
Studies. 
 
Note: A study can be given a maximum of one star for each numbered item within the Selection 
and Outcome categories. A maximum of two stars can be given for Comparability.   
Selection   
1) Representativeness of the exposed cohort  
a) Truly representative (one star)  
b) Somewhat representative (one star)  
c) Selected group  
d) No description of the derivation of the cohort  
2) Selection of the non-exposed cohort  
a) Drawn from the same community as the exposed cohort (one star)  
b) Drawn from a different source  
c) No description of the derivation of the non-exposed cohort  
3) Ascertainment of exposure  
a) Secure record (e.g., surgical record) (one star)  
b) Structured interview (one star)  
c) Written self-report  
d) No description  
e) Other  
4) Demonstration that outcome of interest was not present at start of study a) Yes (one star)  
b) No  
Comparability   
1) Comparability of cohorts on the basis of the design or analysis controlled for confounders  
a) The study controls for age, sex and marital status (one star)  
b) Study controls for other factors (list) _________________________________ 
(one star)  
c) Cohorts are not comparable on the basis of the design or analysis controlled for 
confounders  
Outcome   
1) Assessment of outcome  
a) Independent blind assessment (one star)  
b) Record linkage (one star)  
c) Self-report  
d) No description  
e) Other  
2) Was follow-up long enough for outcomes to occur  
a) Yes (one star)  
b) No  
Indicate the median duration of follow-up and a brief rationale for the assessment 
above:____________________  
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3) Adequacy of follow-up of cohorts  
a) Complete follow up- all subject accounted for (one star)  
b) Subjects lost to follow up unlikely to introduce bias- number lost less than or equal to 
20% or description of those lost suggested no different from those followed. (one star)  
c) Follow up rate less than 80% and no description of those lost  
d) No statement  
  
E-17  
  
Thresholds for converting the Newcastle-Ottawa scales to AHRQ 
standards (good, fair, and poor):  
  
Good quality: 3 or 4 stars in selection domain AND 1 or 2 stars in 
comparability domain AND 2 or 3 stars in outcome/exposure domain  
  
Fair quality: 2 stars in selection domain AND 1 or 2 stars in 
comparability domain AND 2 or 3 stars in outcome/exposure domain  
  
Poor quality: 0 or 1 star in selection domain OR 0 stars in comparability domain OR 
0 or 1 stars in outcome/exposure domain 
